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ABSTRACT 
 
ATM PHOSPHORYLATES SUBUNIT A OF PP2A RESULTING IN ITS NUCLEAR 
EXPORT AND SPATIOTEMPORAL REGULATION OF THE DNA DAMAGE 
RESPONSE 
 
 
By Amrita Sule, M.Sc.  
 
 
A dissertation submitted in partial fulfillment of the requirements for the degree of 
Doctor of Philosophy at Virginia Commonwealth University 
 
 
Virginia Commonwealth University, 2016 
 
 
Director: Kristoffer Valerie 
Professor, department of radiation oncology 
 
Ataxia telangiectasia mutated (ATM) is a serine-threonine protein kinase and 
major regulator of the DNA damage response (DDR). One critical ATM target is protein 
phosphatase 2A (PP2A) known to regulate diverse cellular processes such as mitosis and 
cell growth as well as dephosphorylation of many proteins during the recovery from the 
DDR while returning the cell to normalcy. Interestingly, ATM and PP2A are known to 
form an auto-regulatory yin-yang kinase-phosphatase relationship. Herein, we show that 
the phosphorylation of the PP2A-Aα structural subunit at S401 by ATM results in nuclear 
export, which regulates the DDR at multiple levels and affects genomic stability and cell 
growth. We generated PP2A-Aα conditional knockout mouse embryonic fibroblasts 
expressing PP2A-Aα-WT, S401A (cannot be phosphorylated), or S401D 
xvi 
 
 
phosphomimetic) transgenes by floxing out the endogenous PP2A-Aα alleles with Cre. 
The S401D mutant cells displayed increased ERK and AKT signaling, resulting in an 
enhanced growth rate. Phosphorylation of PP2A-Aα at S401 caused the dissociation of 
ATM with the holoenzyme, an effect that could be recapitulated with S401D. 
Additionally, the S401A and S401D mutants exhibited significantly more chromosomal 
aberrations and underwent increased mitotic catastrophe after radiation. Both the S401A 
and the S401D cells showed impaired DSB repair (Non-homologous end joining and 
Homologous recombination repair) and exhibited delayed DNA damage recovery, which 
was reflected in reduced radiation survival. Time-lapse video and cellular localization 
experiments showed that the PP2A-Aα subunit was exported to the cytoplasm after 
radiation possibly by CRM1, a nuclear export protein, in line with the very rapid 
pleiotropic effects seen. In conclusion, our study demonstrates using a genetically defined 
system that ATM phosphorylation of a single, critical amino acid S401 is essential for 
regulating DDR. To study how the interplay between ATM and PP2A affects DDR in the 
brain, we are in the process of generating a brain specific PP2A-Aα conditional knockout 
mouse. Loss of many DDR related proteins like ATM and PP2A can lead to severe 
neuropathological effects. This model will be helpful in dissecting the PP2A-Aα/ATM 
regulatory circuit in the brain in response to DDR. 
 
CHAPTER 1: 
 
General introduction 
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DNA damage response  
 
 
Cells encounter thousands of events everyday, which can cause genomic stress and 
ultimately result in DNA damage. Damage could be caused by endogenous agents, like 
reactive oxygen species generated in cell, or during replication due to stalled replication 
forks, as well as damaged telomeres. Exogenous agents like radiation, radiomimetic and 
genotoxic drugs also contribute to DNA damage in cells. Over the years, our cells have 
evolved to elicit a response to cope with such damage (Ciccia and Elledge, 2010; Jackson 
and Bartek, 2009). This response initiated by the cell is termed as DNA damage response 
(DDR), which is a collective term for several cellular signaling pathways, which are set-
off by detection of DNA damage.  
 
DNA damage can be of different types. Replication errors, which result in mismatches, 
deletions and insertions. Base modifications due to oxidation, deamination or 
depurination are some of the common modifications that result in damaged DNA. There 
are instances when exogenous chemical agents cause bulky adducts or cause one DNA 
strand to covalently bind to the other strand causing intra-strand or inter-strand 
crosslinks. UV exposure can induce or single strand breaks (SSBs). Free radicals 
produced as a by- product of endogenous processes or exogenous agents like ionizing 
radiation (IR) can induce the formation of double-strand breaks (DSBs). These different 
kinds of damage evoke distinct repair mechanisms. The cell resolves most of the damage 
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using the DNA repair machinery. However, failure to do so can be deleterious to the cell.  
Of all the types of DNA damage, DSBs are the most lethal (O’Connor, 2015). 
 
When cells encounter damaged DNA, sensor proteins initiate signaling to assess the type 
of damage and elicit an appropriate response by modulating downstream proteins. The 
three well-studied damage sensing proteins in humans belong to the phosphatidyl-
inositol-3’-kinase-related kinase (PI3KK) family of proteins. In an event of DNA 
damage, Ataxia Telangiectasia mutated (ATM), ATM and Rad3-related (ATR) and 
DNA-dependent protein kinase (DNA-PK) get activated and localize at the sites of DNA 
breaks and mediate DNA repair via modulating survival and death signaling (Shiloh and 
Ziv, 2013). These PI3KKs direct a coordinated DDR (Valerie and Povirk, 2003) by 
acting at several levels, including cell cycle checkpoints, DNA double-strand break repair 
and apoptosis (Abraham, 2001; Shiloh, 2003). 
 
ATM, ATR and DNA-PK have similar structure with a variable number of HEAT repeats 
at the N-terminus, a FAT domain and a FATC domain at the C-terminus. These kinases 
phosphorylate their substrates on signature Ser /Thr residues followed by a Gln residue 
(SQ/TQ).  Despite some similarities in structure and functionality, these kinases play 
distinct roles in DDR regulation. DNA-PK primarily promotes repair of DSBs by non 
homologous end joining (NHEJ). ATM is an important checkpoint regulator and activates 
repair by homologous recombination repair (HRR). SSBs, which arise due to collapse of 
a replication fork or UV irradiation induced stress, activate ATR (Ceccaldi et al., 2016)  
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Cell Cycle Checkpoint activation  
 
 
In addition to facilitating efficient DNA repair, DDR also tightly regulates cell cycle 
progression in an event of damage. The cell cycle is controlled by cyclin-dependent 
kinases (CDK). DDR effector proteins limit CDK activity to prevent premature entry into 
the respective stages of cell cycle.  The checkpoint kinases Chk1 and Chk2 are direct 
substrates of ATR and ATM respectively (Bartek and Lukas, 2003; Smits et al., 2006). 
 
 
The G1/S checkpoint is primarily controlled by p53. ATM as well as Chk2 are the main 
mediators of G1/S checkpoint. Upon DNA damage, p53 is rapidly stabilized as a result of 
phosphorylation by ATM, ATR, Chk1 and Chk2 kinases. When phosphorylated at S15, 
p53 upregulates transcription of p21. p21 is a CDK inhibitor, that suppresses cyclins E/A 
and therefore mediates G1/S arrest (Bartek and Lukas, 2001). 
 
 
The intra-S checkpoint delays progression through S phase by preventing replication of 
damaged DNA. ATM-mediated phosphorylation of BRCA1, FANCD2, Chk2 and Nbs1 
is required for effective intra-S checkpoint. Also, Chk1, activated by ATR, can 
phosphorylate Cdc25a and promote its proteasome-mediated degradation, subsequently 
inhibiting CDK activity (Bartek and Lukas, 2003; Mailand et al., 2000).  
 
The G2/M checkpoint ensures that the damage is repaired before proceeding to mitosis 
and cell division. This checkpoint is activated by ATM/ATR-mediated activation of  
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Figure 1-1: Cell cycle checkpoint control post DNA damage  
 
The three main checkpoints initiated post DNA damage occur through G1/S transition, 
within the S phase and the G2/M transition. Adapted from Abraham (2001). 
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Chk1. Chk1 phosphorylates Cdc25c and causes its sequestration by 14-3-3 in the 
cytoplasm. Cdc25c can no longer dephosphorylate cyclin B/Cdc2, thus causing G2/M 
arrest (Taylor and Stark, 2001). 
 
The Spindle assembly checkpoint, also known as M-phase checkpoint, ensures that each 
of the duplicated chromosomes is attached to mitotic spindles before their separation. At 
the end of mitosis, APC/C-CDC-20 activity is increased in the cell to degrade all the 
mitotic determinants. The spindle assembly checkpoint is mediated by early mitotic 
inhibitor 1 and 2, which inhibit APC/C-CDC-20 activity. Also, Shugoshin 1 (Sgo1) 
mediated PP2A-B56 recruitment, dephosphorylates Plk1 and prevents dissociation of 
cohesion and thereby prevents premature segregation of sister chromatids.  When cells 
enter into mitosis despite unrepaired or damaged DNA, apoptotic cell death is triggered, 
known as mitotic catastrophe.(Castedo et al., 2004). 
 
All these checkpoints are safeguard mechanisms for the cell to progress from one phase 
to other, ensuring that the damage is resolved before cell cycle progression (Fig. 1-1).  
Timely activation of these check points is essential to maintain genomic stability in an 
event of DNA damage.   
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Double-strand break repair 
 
 
DSBs are detrimental to the cell if left unrepaired (Dasika et al., 1999; Illiakis, 1991). 
The two primary high fidelity processes used by cells to repair DSBs are the classical 
non-homologous end joining (c-NHEJ) pathway and the homologous recombination 
repair (HRR) pathway. Cells also use other DSB repair pathways like alternative end 
joining (Alt-EJ) and single strand annealing (SSA); however, these pathways are 
intrinsically mutagenic. These error prone pathways are known to give rise to genomic 
rearrangements leading to oncogenic transformation (Ceccaldi et al., 2016).  
 
Nonhomologous end joining pathway  
 
 
DSB repair by c-NHEJ pathway occurs throughout the cell cycle but it is predominant in 
the G1/G0 phase of cell cycle. NHEJ, though error prone, is extremely efficient in 
maintaining genomic integrity because of its fast kinetics (Ceccaldi et al., 2016). This 
repair involves ligation-mediated repair of DSBs and is independent of sequence 
homology. c-NHEJ is coordinated by the action of DNA-PK, a holoenzyme comprised of 
Ku heterodimer, Ku70 (70 kDA), Ku80 (86 kDA) and a large catalytic subunit (DNA-
PKcs). The DSBs are recognized by heterodimer proteins Ku70/Ku80, that bind to the  
DSB ends and stabilize them. Ku70/Ku80 proteins act as sensors and recruit DNA-PKcs 
at the DSBs. At the break, DNA-PK functions as a kinase to synapse the ends and target 
other NHEJ factors at the DSBs. A multimeric complex consisting of DNA Ligase IV,  
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Figure 1-2: Nonhomologous end joining pathway  
 
The DSB is recognized by KU70/KU80 heterodimer and recruits DNA-PKcs. The XLF 
protein, DNA ligase IV and XRCC5 complex is recruited at the DSBs. Artemis carries 
out end processing on the unligatable ends before they are joined. Adapted from Valerie 
and Povirk (2003) 
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XRCC4 and XLF are recruited and activated in a DNA-PKcs dependent manner (Fig. 1-
2). Artemis functions as an endonuclease that mediates end-processing of the DNA 
overhangs in case of unligatable termini (Povirk et al., 2007). DNA ligase IV mediates 
DNA-strand joining and exists in a complex with XRCC4 (Critchlow et al., 1997; Robins 
and Lindahl, 1996). Pol μ and λ polymeRASes are associated with c-NHEJ to fill in 
nucleotide overhangs (Ma et al., 2004). XLF stimulates gap filling (Akopiants et al., 
2009). These NHEJ players have mechanistic flexibility, which permits NHEJ to function 
on a wider range of DNA starting structures. 
 
Homologous recombination repair 
 
 
HRR is a critical DSB repair pathway. It repairs the DSBs using a sister chromatid or 
homologous chromosomes and hence is restricted to the S/G2 phase of cells cycle. It is 
regulated by ATM at DSBs and ATR at SSBs (stalled/collapsed replication forks), which 
have the potential to be converted to DSBs (Golding et al., 2004; Wang et al., 2004). 
HRR is initiated by 5′ -3′ resection of the DNA ends resulting in two single DNA strands. 
The heterotrimeric complex Mre11-Rad50-Nbs1 (MRN) binds to the DNA ends 
(Williams et al., 2009).  The single-stranded DNA coated with Rad51 begins strand 
invasion and searches for a homologous region within the DNA duplex and forms a D-
loop structure (Barzel and Kupiec, 2008). DNA polymeRASe extends the invading strand 
to form a Holliday Junction. The second DSB enters the D loop and a double Holliday  
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Figure 1-3: Homologous recombination repair pathway  
 
Post detection of DNA damage, HRR proceeds to resect the DSB ends exposing a 3’ 
single-stranded DNA. RPA coats the single strand of the DNA, which is then replaced by 
Rad51. Strand invasion takes place after locating the homologous sequence and results in 
formation of a D-loop structure. The invading 3’ strand is extended by polymeRASe. 
Resolution of the Holliday junction can cause crossing over and swapping of arms 
between the interacting chromatids.   
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Junction is formed (Barzel and Kupiec, 2008). The resolution of two-cross strand or 
Holliday Junctions should result in intact double-stranded products (Fig. 1-3). 
 
Choice of DSB repair pathways 
 
 
The choice of DSB repair pathway depends on many factors, one of the determining 
factors being extent of end resection. A balance between BRACA1 and 53BP1 decides 
which pathway is ultimately chosen. BRCA1 binds to CtIP and MRN complex at DSBs 
and promotes repair by HRR (Hu et al., 2014). Conversely, 53BP1 blocks resection by 
preventing access of CtIP at the breaks, thereby directing repair via c-NHEJ. This 
function of 53BP1 is dependent on its phosphorylation by ATM (Bunting et al., 2010).  
 
There are other pathways that also mediate DSB repair. Once resection has occurred, it 
leaves the choice of repair by HRR or by the other homology-based pathways SSA and 
Alt-EJ. Although Alt-EJ has always been thought to be a backup pathway for c-NHEJ, 
recent studies have shown that it competes with HRR for repair of DSBs. (Ceccaldi et al., 
2016). In Alt-EJ pathway, PARP1 is thought to function in recruitment of repair factors 
like Polθ and mediate the microhomology dependent repair. Loss of PARP1 in HRR-
compromised cells caused synthetic lethality suggesting that PARP-mediated Alt-EJ 
compensates for HRR deficiency (Bryant et al., 2005; Farmer et al., 2005). 
 
12 
 
 
Phosphatases and Kinases 
 
 
The DDR is a synchronized effort of many phosphatases and kinases.  The PI3KKs 
(ATM, ATR and DNA-PK) can phosphorylate hundreds of proteins in response to 
exogenous DNA damage. DDR is a coordinated phosphorylation-signaling cascade, 
which involves tightly regulated post-translational modifications of proteins, resulting in 
their inhibition, activation or change in subcellular localization. Studies are being carried 
out to examine the dynamics of phosphorylation events during and after DDR (Bennetzen 
et al., 2010). Therefore, to bring the cell to its native state, reversible phosphorylation is 
of utmost importance (Hunter, 1995; Pawson and Scott, 1997).  Phosphatases are the 
evident candidates that can aid in regulating balance of the phosphorylation events post 
DDR. Thus, phosphorylation and dephosphorylation can act as an ON or OFF switch for 
the activity of the target protein. However, phosphatases not only play a role in 
counteracting the DDR related phosphorylation events but also play a role in initiating 
DNA repair via dephosphorylation of key proteins (Lee and Chowdhury, 2011). For the 
purpose of our study we will be reviewing ATM kinase and protein phosphatase 2A in 
detail. 
 
ATM kinase  
 
 
Ataxia-Telangietasia mutated (ATM) is a Ser/Thr kinase. The gene encoding ATM is 
mutated in the autosomal recessive disorder Ataxia-Telangietasia (A-T), which is 
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characterized by increased genomic instability, neurodegeneration, predisposition to 
cancer and immunodeficiency (Kastan et al., 2001). Cells from patients with A-T display 
extreme radiosensitivity (Taylor et al., 1975). Ectopic expression of ATM in these cells 
were able to rescue the A-T features (Zhang et al., 1998; Ziv et al., 1997). ATM, a 
PI3KK family member, shares sequence similarity in their C-terminal region with other 
members, ATR and DNA-PKcs. The C-terminal consists of kinase, FAT (conserved in 
FRAP, ATM and TRRAP) and the FATC (FAT-C terminal domain). The N-terminal is 
among the PIKK members consists of variable number of HEAT 
(Huntington/Elongation/A-subunit/Tor) repeats.  
 
ATM kinase is a master regulator of the cellular response to DSBs and relays a wide 
spread signal to downstream proteins to initiate the DDR. ATM exists as an inactive 
dimer in the cell. In the event of a DSB, ATM is recruited to the DSB by the MRN 
complex (Lee and Paull, 2005), which acts as a damage sensor. The interaction between 
Nbs1 and ATM is crucial for ATM’s recruitment and retention at the DSBs 
(Difilippantonio and Nussenzweig, 2007; Lee and Paull, 2005). The ATM dimer 
undergoes trans auto-phosphorylation at the S1981 residue in the FAT domain and 
dissociates into the active monomeric form (Bakkenist and Kastan, 2003). ATM also 
undergoes TIP60 mediated acetylation on K3016 residue, which is essential for its 
activation (Sun et al., 2005, 2007). Three other autophosphorylation sites have also been 
identified on ATM; however, abrogation of those affect DDR in humans but not in mice 
(Kozlov et al., 2006, 2011).  Phosphorylation at S1981 of ATM is regulated by PP2A, 
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which binds to ATM and prevents its activation in the absence of DNA damage 
(Goodarzi et al., 2004).   
 
At the site of DNA damage ATM phosphorylates the histone variant H2AX at S139 also 
referred to as γ-H2AX (Rogakou et al., 1998). γ-H2AX starts accumulating at the damage 
site as early as one minute after damage and appear as discrete foci. This is followed by 
recruitment of MDC1, which interacts with γ-H2AX and MRN and mediates retention of 
ATM at the damage sites (Stucki et al., 2005). H2AX and MDC-1 act as scaffold proteins 
and recruit downstream repair proteins like 53BP1 and BRCA1 complex (Shiloh and Ziv, 
2013). In response to DNA damage, ATM mediates checkpoint activation via 
phosphorylation-dependent activation and inhibition of several effector proteins. We have 
discussed some of the aspects of the same in the previous section of this chapter.  
ATM-mediated DDR is an example of multilayered regulation of several pathways. For 
example, ATM modulates the activity of protein kinases like Chk2, which in turn 
phosphorylate their own substrates. Thus, ATM lies at the apex of a very extensive 
network. One of the well-studied targets of ATM is p53. ATM activation stabilizes p53 
and drives the expression of many genes that promote programmed cell death. ATM can 
also phosphorylate the IKKγ subunit of IKK. IKK mediated phosphorylation degrades the 
NF-κB inhibitor, IκBα. This releases NF-κB from IκBα in the cytoplasm and imports it to 
the nucleus where it drives the expression of anti-apoptotic genes. Thus, ATM-mediated 
phosphorylation on its substrates aids in making a decision between cell survival and 
activation of programmed cell death. However, there are several more players involved 
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whose action is dependent on specific post translational modifications (Shiloh and Ziv, 
2013).  
 
Although traditionally considered as a nuclear protein, studies have revealed cytoplasmic 
function of ATM, especially in insulin-mediated signaling. Insulin stimulation can 
activate ATM kinase, which then phosphorylates 4E-BP1, thus implicating ATM directly 
in the insulin signaling pathway (Yang and Kastan, 2000). ATM being a kinase with the 
capacity of modulating a vast number of proteins, ongoing studies are looking at the role 
of ATM exclusive to DDR.    
 
Protein Phosphatase 2A 
 
 
Ser/Thr phosphatases control a number of cell signaling pathways and crucial processes 
like DNA replication and gene transcription. Protein phosphatase 2A (PP2A) and Protein 
phosphatase 1 (PP1) are two major Ser/Thr phosphatases and together are responsible for 
almost 90% Ser/Thr phosphatase activity in a cell. Both PP1 and PP2A are sensitive to 
okadaic acid (OA). OA exhibits much greater affinity and inhibition efficacy towards the 
PP2A (IC50=0.1–0.3 nM for PP2A vs 15–30 nM for PP1) (Cohen et al., 1989; Favre and 
Turowski, 1997; Swingle et al., 2007). PP2A is ubiquitously expressed in eukaryotic cells 
and regulates cell cycle, cell proliferation, cell survival and apoptosis (Janssens and 
Goris, 2001; Perrotti and Neviani, 2013; Schönthal, 2001; Seshacharyulu et al., 2013).  
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PP2A regulates many cellular processes including DNA replication, cell cycle 
progression and cell differentiation.  The PP2A holoenzyme is a heterotrimer comprised 
of a scaffolding subunit (A), a catalytic subunit (C), and a regulatory subunit (B). In 
mammalian cells it exists either as a heterodimer (AC) or a heterotrimer (ABC) (Janssens 
et al., 2008) (Fig. 1-4). The A-subunit has two isoforms Aα and Aβ (Encoded by 
PPP2R1A or PPP2R1B respectively), which are 86% identical. The Aα isoform is 
expressed at much higher levels relative to the Aβ isoform (Hemmings et al., 1990) and 
90% of the holoenzymes are comprised of the Aα isoform (Yang and Phiel, 2010). The 
PP2A-Aα and the Aβ isoforms have distinct functions, which has been documented by 
their differential B-subunit binding (Zhou et al., 2003). Also, in a Xenopus system, Aα 
and Aβ are involved at different developmental stages (Hendrix et al., 1993) and in mice, 
the Aβ subunit is not able to compensate for Aα (Eichhorn et al., 2009). Each isoform is 
shaped like a horseshoe composed of 15 non-identical internal repeats of a 39 amino acid 
sequence, termed as HEAT (Huntington/Elongation/A-subunit/Tor) motif. Each repeat is 
composed of two α helices connected by an intra-repeat loop (Walter et al., 1989; 
Hemmings et al., 1990; Ruediger et al., 1992).  
 
The C-subunit also exists in two isoforms Cα and Cβ (encoded by PPP2R1C and 
PPP2R1C respectively) that share 97% sequence identity. The Cα isoform is more 
abundant than the Cβ isoform (Khew-Goodall and Hemmings, 1988). Previous studies 
indicate that the diversity of PP2A holoenzymes is mainly controlled by its regulatory B- 
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Figure 1-4: Complexity of the PP2A holoenzyme 
 
Schematic of PP2A holoenzyme with the different isoforms of scaffolding (blue), 
regulatory (green) and the catalytic subunit (yellow). Adapted from Vishrup and 
Shenolikar (2009). 
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subunit. The B subunits of PP2A are classified into four distinct families, B/B55 
(PPP2R2), B’/B56 (PPP2R5), B’’(PPP2R3) and B’’’/Striatin (PPP2R4) 
(Janssens et al., 2008; Mayer-Jaekel and Hemmings, 1994). So far, at least 26 sub types 
of the B subunit have been identified (Seshacharyulu et al., 2013; Zolnierowicz et al., 
1994). For complete activation, the AC core dimer binds to a specific B-subunit to form a 
fully functional heterotrimeric protein, which determines its substrate specificity and 
subcellular localization. 
 
Before being assembled into a holoenzyme, activation of PP2A is mediated by 
phosphotyrosyl phosphatase activator or PP2A specific phosphatase activator (PTPA) 
(Guo et al., 2014). PTPA mediates the loading of catalytic metal ions essential for p-
Ser/Thr phosphatase activity (Guo et al., 2014). Post-translational modification on 
distinct subunits of PP2A also modulates the activity of the holoenzyme (Fig. 1-5).  
Methylation on the C terminal region of PP2A-C subunit by leucine carboxyl 
methyltransfeRASe-1 (LCMT1) is required for its holoenzyme assembly (De baere et al., 
1999; Lee et al., 1996). Conversely, PP2A-specific methylesteRASe (PME-1), binds to 
the C-subunit active site and removes the methyl group to inactivate it (Xing et al., 2008).  
Studies have suggested that methylation on the C-subunit can affect the composition and 
substrate specificity of the holoenzyme (Janssens et al., 2008). Tyr-307 phosphorylation  
on the C-subunit by src-kinase or in response to growth signaling, also causes its 
inactivation (Chen et al., 1992). Three sites (S303, T268, S314) were identified on the A-
subunit, which when phosphorylated, affect the C-subunit association and signaling in 
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Figure 1- 5: Post-translational modifications on PP2A that affect its activity 
 
Methylation on the C-subunit is essential for activation of PP2A, whereas Y307 
phosphorylation cause its inactivation. There exist an array of phosphorylation sites on 
different B-subunits that regulate its activity. Post-translational modifications on the A 
subunit in form of Ser/Thr phosphorylation can affect the C-subunit binding.  
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the heart (Kotlo et al., 2014). 
 
Also, viral protein from certain DNA tumor viruses can bind to the PP2A holoenzyme by 
replacing the B-subunit and thereby altering its activity and subcellular localization. The 
viral proteins; Polyoma small t (Pyst), Polyoma middle T (PyMT) and simian virus    
small t (ST) can form a complex with the PP2A core and alter its activity (Chen et al., 
2004; Pallas et al., 1990; Walter et al., 1990). These interactions mainly facilitate cellular 
transformation via alteration of growth signaling pathways (Campbell et al., 1995).   
Studies are being carried out to identify additional post-translational modifications on 
PP2A subunits, which will give a perspective about its role in different cellular processes. 
 
 
Given the complexity of PP2A composition, it has been suggested that PP2A can 
dephosphorylate over 300 substrates (Peng and Maller, 2010). Most of these substrates 
are involved in cell cycle regulation and cell proliferation pathways (Peng and Maller, 
2010). PP2A regulates the Wnt, mTOR and MAP kinase pathways which play an 
important role in cell cycle initiation, cell proliferation and growth arrest (Wlodarchak 
and Xing, 2016). It regulates the Wnt signaling pathway both positively and negatively. 
PP2A-Bα dephosphorylates β-catenin to promote expression of Wnt responsive genes 
(Zhang et al., 2009). Moreover, in the absence of Wnt signaling, PP2A-B56α can also 
remove the inhibitory phosphorylation on GSK3β and promote degradation of β-catenin 
(Mitra et al., 2012).  PP2A negatively regulates mTOR pathway by inhibiting IRS1 of 
insulin (Carlson et al., 2004) signaling or by inhibition of AKT (Kuo et al., 2008). MAP 
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kinase pathway is both positively and negatively regulated by PP2A. In presence of 
growth factors, the growth signal is relayed from the growth receptor to RAS, RAF, 
MEK and ERK. PP2A-mediated dephosphorylation releases RAF and KSR1 from 14-3-
3, thereby activating RAF. KSR 1 is required for activation of downstream MEK (Ory et 
al., 2003). PP2A negatively regulates the MAP kinase pathway upstream by activating 
Sprouty which prevents RAS complex formation (Lao et al., 2007).   
 
PP2A profoundly impacts DDR by modulating the activity of the PIKKs (ATM, ATR 
and DNA-PK) as well as Chk1 and Chk2 kinases (Lee and Chowdhury, 2011). 
Dephosphorylation of γ-H2AX at DSBs by PP2A is essential for efficient repair 
(Chowdhury et al., 2005). It promotes NHEJ by dephosphorylating DNA-PKcs, KU70/80 
(Wang et al., 2009). Depletion or inhibition of PP2A results in impaired DDR, e.g., 
deficiency in IR-induced G2/M arrest (Yan et al., 2010). PP2A, by associating with its 
specific B-subunit, tightly regulates cell cycle at various stages and is vital in DDR, the 
details of which are discussed in the chapters to follow.  
 
As it is clear from the various studies reviewed here that DDR response is an orchestrated 
effort of many proteins, with kinases and phosphatases being the chief modulators. It is 
therefore crucial to understand the intricate regulation among these proteins. The study 
herein focuses on ATM kinase and PP2A, as extensively discussed above. Our study 
aims to address how ATM and PP2A modulate each other’s activity and control DSB 
repair and pro survival via spatio-metric regulation.  
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CHAPTER 2: 
 
Generation and characterization of PP2A-Aα KO 
Mouse Embryonic Fibroblasts 
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Introduction 
 
 
 
PP2A has been implicated in a variety of human cancers playing a role as a tumor 
suppressor, where it acts by negatively regulating some cancerous signaling pathways. It 
is a negative regulator of key signaling pathways like RAF/MEK/ERK and PI3K/AKT 
pathways, NF-ΚB, c-MYC, and WNT signaling (Eichhorn et al., 2009). Aberrant 
activation of these signaling cascades can lead to cancer development. PP2A is mutated 
in a variety of human cancers. Point mutations, deletions as well as mutations that can 
generate alternate transcripts are found in different PP2A subunits (Perrotti and Neviani, 
2013; Strack et al., 1999). Many of these mutations result in disruption of the PP2A 
holoenzyme thereby affecting its enzymatic activity.     
 
 
Studying transformation in human cell culture models over time has elucidated role of 
various signaling pathways in cancer. Studies by the Weinberg group and others 
demonstrated that expression of telomerase catalytic subunit (hTERT) in combination 
with the simian virus small t (SV40-ST) antigen and oncogenic allele of H-RAS caused 
transformation of several human cell lines. This transformation requires the interaction of 
the ST with PP2A (Hahn et al., 1999; Mumby, 1995; Yu et al., 2001b) consequently 
suppressing PP2A activity by displacing the regulatory B subunit (B56α, B56γ and 
PR72/PR130 have been identified) (Sablina et al., 2010). ST bound to the PP2A –AC 
heterodimer directly regulates AKT dephosphorylation at Serine 473 (Rodriguez-Viciana 
et al., 2006).  Cells in which PP2A-AC is bound to ST show increased proliferation as 
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well as upregulation of the MAP kinase pathway (Sontag et al., 1993a; Ugi et al., 2002).  
Polyoma small (PyST) and polyoma middle T (PyMT) also forms a complex with the 
PP2A dimer and this interaction is essential for cellular transformation (Pallas et al., 
1990; Walter et al., 1990). Association of PyMT with PP2A-AC preferentially activates 
the MAP kinase pathway, which suggests that PyMT possibly displaces the B55α or B56 
subunit and promotes unregulated growth (Rodriguez-Viciana et al., 2006). Loss of B56γ 
has been shown to activate the PI3K/AKT pathway (Chen et al., 2004). A previous study 
from our lab has suggested that ATM mediates the phosphorylation of AKT at S473 via 
an OA sensitive phosphatase (Golding et al., 2009). Also, OA at lower concentrations 
(PP2A IC50) reduces p-AKT (S473) levels relative to higher concentration (PP1 IC50) 
(Golding et.al. unpublished). We think that PP2A, an OA sensitive phosphatase, is 
regulated downstream of ATM, which could further regulate AKT dephosphorylation. 
We looked at AKT phosphorylation in presence and absence of ATM inhibitor (KU-
60019) in the glioma cell lines U87 and U1242 as well as HEK293 and HEK293T cells 
(Golding et al., unpublished). Inhibition of ATM reduced p-AKT levels in U87, U1242 
and HEK293 cells, but it failed to alleviate AKT phosphorylation in the 293T cells, that 
express the SV40 virus. Likewise, when PyMT was overexpressed in the glioma cells 
lines, AKT phosphorylation was not affected in cells treated with KU-60019 in presence 
and absence of IR (Golding et al., unpublished). This suggests that ATM regulates 
phosphorylation of AKT via inhibition of PP2A activity.  
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Both MAP kinase and PI3K/AKT pathways are governed by intracellular and 
extracellular stimuli to control cell proliferation, cell motility as well as metabolism.  
Traditionally, it has been suggested that these cascades function as two independent 
parallel pathways.  However, studies have demonstrated that there are multiple points in 
these pathways where crosstalk exists (Fey et al., 2012). Coordinated actions of these 
pathways determine the cellular fate. However, dysregulation can often lead to 
deleterious effects. Both MAP Kinase and PI3K/AKT pathways have a mechanism to 
negatively feed into the other. Such cross inhibition has been revealed by chemical 
inhibition of specific players of these pathways. AKT negatively regulates ERK 
activation via inhibitory phosphorylation of RAF in response to IGF1 (Dhillon et al., 
2002; Guan et al., 2000; Zimmermann and Moelling, 1999). Similarly, EGF induced 
ERK activation downregulates AKT phosphorylation via GAB1 (Yu et al., 2001a, 2002).  
Phosphatases like PP1 and PP2A act at several levels to activate or inhibit these 
pathways. PP2A can inhibit MAP kinase pathway by dephosphorylating both MEK1/2 
and ERK1/2 proteins. Conversely, it can activate MAP kinase pathway by taking off the 
inhibitory phosphorylation on RAF. Crosstalk among pro-survival signaling pathways 
can often serve as a compensatory mechanism for cancer cells to dodge cell death. 
 
 
MAP kinase and AKT pathways are also affected by DNA damage. We have previously 
demonstrated that in response to minor DNA damage, ATM mediates activation of the 
MAP kinase family member ERK via AKT, whereas extensive DNA damage abrogates 
phosphorylation of ERK, an important pro-survival molecule (Khalil et al., 2011). 
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Consequently, minor damage will promote DNA repair and cell survival, whereas in case 
of excessive damage, pro-survival signaling is shut off, which could ultimately lead to 
apoptosis or cell death. ATM also controls the activation of AKT, a major pro-survival 
molecule in response to IR and insulin, in an indirect manner (Golding et al., 2009; 
Viniegra et al., 2005a).  Using a small molecule inhibitor KU-60019, we have previously 
reported that inhibition of ATM kinase blocks pro-survival signaling in glioma cell lines 
by reducing AKT (S473) phosphorylation (Golding et al., 2009). In this study we 
observed that OA treatment reduced the effect of KU-60019 on p-AKT levels by 50% 
relative to KU-60019 alone. This study revealed that ATM regulates AKT (S473) 
phosphorylation via an OA-sensitive phosphatase. OA acid inhibits Ser/Thr protein 
phosphatases; with PP1 and PP2A exhibiting much greater affinity and inhibition 
efficacy towards the PP2A (Cohen et al., 1989; Favre and Turowski, 1997; Swingle et al., 
2007). Following DNA damage, ATM activity increases two-to three-fold, which is 
attributed to intermolecular autophosphorylation at the S1981 residue of ATM followed 
by its dissociation to the active monomeric form (Bakkenist and Kastan, 2003). This 
autophosphorylation on ATM is regulated by PP2A in absence of DNA damage. 
Following DNA damage, there is increased phosphorylation on ATM and subsequent 
dissociation of PP2A (Goodarzi et al., 2004). Goodarzi et al. also showed that PP2A 
exerts this regulation on ATM by interacting via the A subunit. However, this association 
was lost in cells, that were irradiated (Goodarzi et al., 2004).   
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The purpose of this study is to elucidate how ATM regulates AKT phosphorylation in 
response to DNA damage as well as in growth factor signaling. ATM which is Ser/Thr 
kinase phosphorylates its substrates on SQ /TQ motifs.  In a study involving high-
throughput substrate analysis of ATM and ATR in response to DNA damage, a vast 
network of over 700 phosphorylated substrates was discovered. This study revealed that 
the S401 site on PP2A-Aα was a highly probable target for ATM (Matsuoka et al., 2007), 
following which Li et al showed that ATM possibly phosphorylates the PP2A-Aα subunit 
on S401 and suppresses its activity (Li et al., 2012). 
 
On the basis of our work and literature, we hypothesized that, on activation, ATM will 
phosphorylate the S401 residue of PP2A- Aα and suppress its activity, thereby increasing 
p-AKT (S373) levels. To study how this is regulated, we generated site-specific mutants 
at S401; the S401D mutant will act as a phophomimetic and the S401A will not be 
phosphorylated. For the purpose of this study we have also generated PP2A- Aα knock 
out MEFs and complemented them with human WT, S401A and S401D PP2A-Aα 
isoforms. 
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Figure 2-1: Hypothesis 
 
ATM when activated can phosphorylate PP2A-Aα, inhibit its activity and thereby 
increase p-AKT level. Inhibition of ATM prevents ATM mediated phosphor-inhibition of 
PP2A and levels of p-AKT are decreased. The phosphorylation on AKT is also controlled 
by kinases like DNA-PKcs. 
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Materials and methods 
 
Mouse information used to create PP2A-Aα conditional knock out (CKO) mouse 
embryonic fibroblasts 
Fvb.129s-ppp2r1ATM1wltr/j mice were purchased from Jackson laboratories as stock 
number 017441. These mutant mice possess loxp sites flanking exons 5-6 of the Aα gene 
(PPPP2R1A) of PP2A (Ruediger et al., 2011). All animal breeding and experiments have 
been approved by Virginia Commonwealth University, IACUC. Mouse embryonic 
fibroblasts (MEFs) were generated from 14 day FVB.129S-PPP2R1ATM1wltr/tm1wltr mouse 
embryos using standard methods (Lei, 2013). All the mouse generation and breeding was 
performed at the VCU Massey Cancer Center Transgenic/Knockout Mouse Core, under 
the direction of Dr. Jolene Windle. 
 
Generation of PP2A-Aα KO MEFs expressing PP2A-Aα WT, S401A and S401D 
mutants 
Mig-Aα-WT retroviral vector, which has a Flag epitope at the NH2 terminus and an 
internal GFP (Chen et al., 2005), was obtained from (Addgene #10884). The S401 and 
S401D mutants were generated using QuikChange site-directed mutagenesis (Stratagene) 
using primers WT to S401A and WT to S401D (Table 1). The vectors were sequenced to 
verify the site-specific mutation at S401. The CKO PP2A-Aα MEFs were subjected to 
spontaneous immortalization via continuous passaging.  We then infected them with the 
retrovirus: MIG-Aα-WT, S401A or S401D. The endogenous PP2A-Aα was floxed out by 
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expression of Cre combinase (Ad-Cre). GFP positive cells were sorted before being 
characterized.   
 
Genotyping  
High pure PCR template preparation kit (Roche Diagnostics Corporation) was used for 
purification of DNA from the MEFs. The PP2A-Aα primers, to verify the CKO and KO 
alleles were used (Table 1). PCR was performed using AmpliTaq Gold® master mix 
(ThermoFisher Scientific) in an Eppendorf thermocycler. Amplified samples were run on 
agarose gel and stained with ethidium bromide. DNA gels were visualized using the Gel 
DocTM XR +Gel documentation system (Bio-Rad).  
 
 
Plasmids  
Mig-Aα WT (Addgene #10884),  pGEX-2T PP2A-Aα : Mig-Aα WT  was cut with  
BamH1 and EcoR1, 1776 bp fragment was cloned in pGEX2T (GE Healthcare Life 
Sciences #28-9546-53), pGEX-2T-p53 (first 100 amino acids of  p53 were cloned on 
pGEX2T Selivanova et al.,1999 ), pRSF-ATM-FAT KD: (1903 bp fragment of codon 
optimized ATM- FAT and Kinase Domain (KD) were cloned in the pRSF-Duet-1 
(EMD Millipore #71341) at EcoRI and XhoI sites using Gibson assembly), Ad-Cre 
recombinase (Vectorlabs #1045) 
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Antibodies 
Antibodies used in western blots were anti-AKT (1:1000) (Cell Signaling Technology), 
anti-p (S473) –AKT (1:1000) (Cell Signaling Technology), anti-PP2A-A (1:1000) (Cell 
Signaling Technology), anti-Flag (Sigma Aldrich), anti-PP2A-C (Millipore), anti-ATM 
(1:1000) (Cell Signaling Technology), anti-ERK (1:1000) (Santa Cruz Biotechnology) 
and anti-p (T202/Y204)-ERK1/2 (Santa Cruz Biotechnology).  
 
Reagents 
Insulin was purchased from Sigma Aldrich and used at a concentration of 350 nM. KU-
60019 was provided by KuDOS pharmaceuticals and dissolved in DMSO and used at a 
concentration of 3 μM.  
 
Cell culture 
Mouse Embryonic Fibroblasts and HEK 293 cells expressing PP2A-Aα WT/S401A and 
S401D were cultured in Dulbecco’s Modified Eagle Medium (DMEM) supplemented 
with 10% Fetal Bovine Serum (FBS) and 1% penicillin-streptomycin antibiotic solution.  
 
Irradiation  
Irradiation was performed using MDS Nordion Gammacell 40 irradiator with Cs-137 
source at a dose of roughly 1.05 Gy/min. 
 
Western Blotting 
Western blotting was performed as previously described (Adams et al., 2010a) with 
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additional modifications. Cells were lysed in 2X Laemmli buffer +β-mercaptoethanol and 
boiled for 10 minutes. Proteins were separated on CriterionTM TGX gels (Bio-Rad 
Laboratories) and transferred to PVDF membranes. Membranes were blocked in casein 
blocking buffer (Sigma Aldrich), following which they were exposed to primary 
antibodies (Dilution 1:1000 in Casein buffer or 5% BSA in TBST) overnight. Protein 
bands were detected and quantified using infrared-emitting conjugated secondary 
antibodies, either anti-rabbit or anti-mouse DyeLight 800 (Rockland Immunochemicals, 
Gilbertsville PA) or anti-rabbit or anti-mouse Alexa 680 (Invitrogen) using the Odyssey 
infrared imaging system from Li-Cor Biosciences (Lincoln, NE). Densitometry was 
performed using LiCor Odyssey Software V3.0. 
 
Crystal Violet staining   
Cells were grown to confluence; media was aspirated off the cells. Cells were stained 
with 0.5% crystal violet in 25% methanol for 15 minutes and the residual stain was 
washed with deionized water.  
 
Growth Assay 
Cell growth was determined by CellTiter-Glo® Luminescent Cell Viability Assay 
(Promega). PP2A-Aα KO MEFs were serially diluted and seeded on a 96-well plate. At 
days 2, 5 and 7 after seeding CellTiter-Glo® reagent was added to the medium at the 
recommended final concentration. Plates incubated for 10 minutes at room temperature 
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(RT). Luminescence was determined EnVision Multilabel reader (PerkinElmer) and the 
values were taken as the measure of cell growth. 
 
Immunoprecipitation 
Flag-PP2A-Aα was immunoprecipitated from HEK-293 cells stably expressing Mig-
Flag-Aα-WT, S401A and S401D. Cells were lysed in EMSA buffer (10mM Tris-HCL 
pH 8.0), 60 mM KCL,1 mM EDTA, 1 mM dithiothreitol 0.1% NP-40, HALT protease 
and phosphatase inhibitors). Lysates were incubated with anti-Flag M2 beads (Sigma) 3-4 
hours. The beads were washed three times in ice-cold PBS, mixed with Laemmli buffer 
+β-mercaptoethanol and boiled for 10 minutes. The lysates were then loaded onto a 
CriterionTM TGX gel and run as earlier described.  
 
Bacterial protein expression 
Fusion proteins (GST-PP2A-Aα, GST-p53 and His-ATM-FAT-KD) were expressed in 
Escherichia coli BL21 cells.  Overnight grown starter culture was added to 200 ml LB 
media and allowed to grow for 1 hour at 37°C. Protein expression was induced by adding 
0.1 mM IPTG. Cells were grown for further 4-5 hours. Cells were spun down and lysed 
in 50 mM tris pH 7.5, 150 mM NaCl and 0.05% NP-40 with 1 mM PMSF and bacterial 
protease inhibitors (Sigma Aldrich).  
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GST-Pull down  
For GST-pulldown assay, GST fusion proteins were bound to Glutathione-Sepharose (GE 
healthcare) for 30 minutes at RT. This was followed by washing of beads (3X) with 
binding buffer (140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4. , 8 mM KH2PO4, pH 7.3; 
PBS). The protein was eluted in 10 mM reduced glutathione in 50mM Tris-HCl (pH 8.0). 
Eluted protein was analyzed by SDS-PAGE followed by western blotting. 
 
His-Pull down  
HA-tagged proteins were bound to Ni-NTA Agarose (Molecular cloning Laboratories). 
Protein purification was performed according to manufacturer’s instructions.   
 
GST-PP2A-Aα and His-ATM FAT KD binding assay 
Purified PP2A-Aα and ATM-FAT-KD were mixed together for 30 minutes on ice. A 
GST pull down assay was done on this mix. GST pull-down assay was also done on 
purified ATM-Fat-KD to eliminate non-specific binding if any.  
 
In vitro kinase assay 
YFP-ATM was immunoprecipitated from HEK 293 cells by GFP TRAP (ChromoTek). 
The immunoprecipitates were suspended in kinase assay buffer containing 2 uCi of [γ-
32P] ATP, 20 μM unlabeld ATP and GST-substrates (GST-PP2Aα or GST-P53). The 
kinase reaction was conducted at 30°C for 20 minutes and stopped by adding 2X 
Laemmli loading buffer. Samples were run on 10% polyacrylamide gels, following which 
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the gel was dried and exposed to a autoradiogram and quantified by a phosphoimager 
(Typhoon) (Canman et al., 1998). 
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Results 
 
Generation of PP2A-Aα KO MEFs complemented with mutant allele 
 
 
The S401 site on PP2A-Aα is an SQ site and has been shown to be phosphorylated by 
ATM following which the activity of PP2A is inhibited (Matsuoka et al., 2007; Li et al., 
2012). The S401 site of PP2A-Aα is highly conserved among mammalian species 
including human and mouse. We generated site-specific mutants at this site, a S401A 
mutant that cannot be phosphorylated and S401D, a phospho-mimetic mutant. Reudigar 
et al. have demonstrated that PP2A-Aα is an essential gene, as knocking out PP2A-Aα 
caused embryonic lethality (Ruediger et al., 2011). To prevent interference from 
endogenous PP2A-Aα, we generated PP2A-Aα Knock out (KO) mouse embryonic 
fibroblasts (MEFs) expressing the respective S401 mutants. The targeting strategy for 
generation PP2A-Aα Conditional Knockout (CKO) mice is outlined in Fig. 2-2A. 
Heterozygous 129S-PPP2R1ATM1wltr/j (CKO/WT) (Ruediger et al., 2011) were bred to 
obtain 129S-PPP2R1ATM1wltr/tm1wltr (CKO/CKO) mice. MEFs generated from 129S-
PPP2R1ATM1wltr/tm1wltr mouse embryos were immortalized. These immortalized MEFs 
were infected with retroviral vectors expressing GFP/Flag- tagged PP2A-Aα WT, S401A 
or a S401D mutant. The endogenous alleles were floxed out by infecting the cells with an 
adenovirus expressing Cre recombinase (Fig. 2-2B). MEFs that were not complemented 
with the GFP/Flag-PP2A-Aα vectors did not survive post floxing of the endogenous  
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Figure 2-2: Scheme for PP2A-Aα knock out 
 
(A) Representation of the WT, CKO and KO alleles of PP2A-Aα before and after Cre-
mediated recombination at loxP (red bars). (B) Scheme for generation of PP2A-Aα CKO 
MEFs. 
A 
B 
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Figure 2-3: Verification of PP2A-Aα knock-out in MEFs 
 
(A) MEFs expressing the Mig-PP2A-Aα-GFP (WT/S401A/S401D. (B) Crystal violet 
staining showing no cells in post expression of Cre-recombinase in MEFs not 
complemented with PP2A-Aα.(C) Genotyping: The PP2A-Aα primers generated a 263-
bp product for WT allele and a 417-bp product for the CKO allele. In cells where Cre has 
been expressed, there would be a 587-bp product for the PP2A-Aα allele. (F) PP2A-Aα 
was detected by western blot in MEFs complemented with the site-specific mutants 
before and after Cre mediated recombination. Endogenous PP2A-Aα was lost post Cre 
expression. GAPDH serves as a loading control. 
C
   
A
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PP2A-Aα (Fig. 2-3B). The knocking out of endogenous PP2A-Aα in the complemented 
MEFs was verified by genotyping and evaluating the protein levels (Fig. 2-3C and 3D). 
 
Phosphorylation of PP2A-Aα at S401 increases pro-survival 
 
 
We and others have previously reported that ATM stimulates insulin- and radiation-
induced phosphorylation of AKT at S473 (Golding et al., 2009; Viniegra et al., 2005a).  
Moreover, our studies and literature have indicated that ATM-mediated phosphorylation 
at S401 on PP2A inhibits its activity, thereby downregulating AKT signaling (Golding et 
al., 2009; Li et al., 2012). To validate this, serum-starved PP2A-Aα KO MEFs expressing 
Flag-tagged PP2A-Aα WT, S401A or S401D mutant were treated with insulin. We 
observed that S401D-expressing cells show elevated p-AKT (S473) levels post insulin 
treatment (Fig. 2-4A and 4B). This may well be due to reduced phosphatase activity of 
the phophomimetic S401D mutant form as hypothesized. Consistently with the up 
regulation of p-AKT, a pro-survival molecule post insulin treatment, MEFs expressing 
S401D mutant also have increased growth rate (Fig. 2-4C).  However, the basal levels of 
p-AKT (S373) did not show any difference amongst the mutants in unstarved or starved 
cells (Fig. 2-4D). Since PP2A also regulates the MAP kinase pathway (Silverstein et al., 
2002), we looked at the pERK1/2 basal levels in these cells. The cells expressing S401D 
showed elevated pERK1/2 levels relative to the cells expressing WT and S401A mutant 
(Fig. 2-5).  
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Figure 2-4: Pro-survival signaling is elevated in S401D expressing MEFs 
 
(A & B) PP2A-Aα KO MEFs (WT, S401A OR S401D) were serum starved for 16 hours 
and treated with 350 nm insulin for 15, 30 or 60 min and cells were harvested for western 
blotting analysis. p-AKT (S473)  levels were normalized to total AKT protein levels. 
GAPDH serves as a loading control. (C) PP2A-Aα KO MEFs (WT, S401A OR S401D) 
were grown at different dilutions. Growth was determined Celltiter-glo® after 2, 5, and 7 
days. Data points; growth, Relative Luminescence Units (RLU). Error bars; SEM n = 3.  
 
A 
B
 
C 
41 
 
 
 
 
      
 
 
 
 
Figure 2-5: p-ERK basal levels are increased in S401D expressing MEFs 
 
PP2A-Aα KO MEFs (WT, S401A OR S401D were treated with or without serum-free 
media for 16h and harvested for western blot analysis. P-AKT (S473) levels were 
normalized to total AKT protein levels. P-ERK (T202/Y204) levels were normalized to 
total ERK levels. 
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Phosphorylation of PP2A-Aα at S401 causes dissociation of the holoenzyme 
 
 
PP2A-A interacts with ATM kinase at amino acids (250-522, 1245-1435 and 2427-2841) 
(Goodarzi et al., 2004) (Fig. 2-6A). To determine if phosphorylation at S401 of PP2A-Aα 
affects binding with ATM, we analyzed the Flag-PP2A-Aα immunoprecipitates for the 
presence of endogenous ATM, AKT and the catalytic subunit of PP2A (PP2A-C) in 
HEK293 cells. We found a strong association of ATM, AKT and PP2A-C with the WT 
and the non-phosphorylatable (S401A) PP2A-Aα, but not with the phosphomimetic 
PP2A-Aα (S401D) (Fig. 2-6B). Lack of association of PP2A-C with the S401D implies 
that phosphorylation at the S401A site of PP2A-Aα results in inhibition phosphatase 
activity. We also pursued molecular modeling studies in collaboration with Dr. Kellogg 
from Department of Medicinal chemistry in School of Pharmacy. Dr. Mosatafa Ahmed 
from his lab helped us with these studies A 6 ns molecular dynamics run using implicit 
solvent was done on the S401-phosphorylated PP2A-Aα chain alone as well as the 
unphosphorylated structure as a control. The phosphorylation of S401 induced a local 
movement in the helices around it and ultimately caused a slight conformational change 
of the whole protein especially at its N-terminus distorting the horseshoe shape of the 
subunit. This did not happen in the control simulation and might potentially cause the 
dissociation of the PP2A complex (Data not shown). Altogether this suggests that 
phosphorylation at S401 of PP2A-Aα could cause dissociation of the holoenzyme which 
further increases pro-survival signaling.  
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Figure 2-6: Phosphorylation at S401 of PP2A-Aα prevents binding of ATM, AKT 
and the C-subunit 
                                
(A) Schematic of regions of the ATM protein with which PP2A-A interacts. (B) HEK 
293 cells stably expressing Flag- tagged WT, S401A and S401D PP2A-Aα were 
harvested and cell lysates were immuno-precipitated with anti-Flag beads and examined 
for ATM, AKT and PP2A-C binding by western blot analysis.  
                                                                   
A 
B
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PP2A-Aα interacts with FAT kinase domain of ATM and is phosphorylated by 
ATM in vitro 
 
 
In a yeast system, Goodarzi and colleagues have demonstrated that PP2A-A interacts 
with ATM. Also, in an in vitro study, fragments of ATM (covering the entire protein 
sequence) were incubated in irradiated and un-irradiated cell extracts. PP2A-A from the 
un-irradiated lysates bound to 250-522, 1245-1435 and 2427-2841 amino acids of ATM 
kinase (Goodarzi et al., 2004). The 2427-2841 amino acid residues overlap with the FAT-
KD of ATM (Fig. 2-6A). We expressed the codon-optimized FAT - kinase domain 
(FAT-KD) of ATM with a His tag and the GST tagged PP2A-Aα in bacterial cells. The 
two proteins were purified and GST pull-down was performed on the mixture of the two 
recombinant proteins.  In line with the data from Goodarzi and colleagues, we saw that 
GST-PP2A-Aα interacted with the FAT-KD of ATM (Fig. 2-7).  ATM kinase 
phosphorylates its substrates on an SQ/TQ motif. YFP-ATM was immunoprecipitated 
from HEK-293 cells using the GFP trap (Chromtek) (Fig. 2-8A). We performed an in 
vitro kinase assay to show that full length ATM phosphorylates PP2A-Aα in vitro. This 
phosphorylation was reduced in presence of ATM inhibitor (KU-60019). Phosphorylation 
or the kinase activity of ATM towards the substrates was measured by looking at the 
incorporation of [γ-32P] ATP on the substrate proteins. GST–p53, which is a known 
substrate of ATM, was used as a control (Fig. 2-8B).  
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Figure 2-7: PP2A-Aα binds to the FAT kinase domain of ATM in vitro 
  
Lane 1 and 2: Affinity purification of GST-PP2A-Aα and His- ATM –FAT-Kinase 
Domain.  Lane 3,4 and 5: Controls for non-specific binding. Lane 6: PP2A-Aα binds to 
His-ATM –FAT-KD in vitro. Proteins were examined for PP2A-A and ATM-FAT-KD 
by western blot analysis. Bottom Panel: Merged western blot of ATM (Red-Alexa680) 
and PP2A-Aα (Green- Dylight 800). 
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Figure 2-8: ATM kinase phosphorylates PP2A-Aα in vitro 
 
(A) Western blot showing the immuoprecipitated YFP-ATM (middle lane). (B) Top 
panel:  YFP-ATM phosphorylates GST-p53 (lane 2) and GST-PP2A-Aα (lane 5). 
Phosphorylation is reduced in presence of KU-60019 (lane 3 and lane 6). Bottom panel: 
Coomassie stained image of the gel showing equal loading of the GST-p53and GST 
PP2A-Aα in all the lanes. 
B
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Chapter summary  
 
 
 
Existing literature from various groups and our lab have put forth evidence that ATM 
regulates AKT phosphorylation via an OA-sensitive phosphatase. On exposure to IR, p-
AKT levels decreased in U87, U1242 as well as HEK 293 cells in presence of ATM 
inhibitor KU-60019, but not in HEK 293T cells.  The HEK 293T cells express a stably 
integrated copy of SV40 DNA. They express the large-T (LT) antigen as well as an 
unspliced SV40 early mRNA that encodes the small-T (sT) antigen (Fu and Manley, 
1987; Pear et al., 1993).  The ineffectiveness of KU-60019 in these cells could be because 
of downregulation of PP2A by its association with the SV40 ST, thereby reducing its 
dephosphorylation function towards p-AKT. Likewise, in U87 and U1242 cells 
overexpressing PyMT, ATM inhibition did not lower p-AKT levels as seen in the control 
cells.  Current understanding of the role of viral oncoproteins in cellular transformation 
via PP2A as well as our data supports our hypothesis that PP2A functions downstream of 
ATM kinase and further regulates the dephosphorylation of AKT.   
 
Herein we have established a genetic model for studying the site-specific modification at 
S401 of PP2A-Aα without interference from the endogenous protein. We effectively 
floxed out the endogenous PP2A-Aα alleles in MEFs and complemented it with the 
human PP2A-Aα WT, S401A or S401D.  Cells floxed by Cre recombinase but not 
complemented with the WT and mutant copies failed to survive, which recapitulated the 
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study performed by Ruediger et al. that the PP2A-Aα is an essential protein (Ruediger et 
al., 2011).  
 
Being the master regulator of DNA damage response, ATM has been traditionally 
considered as a nuclear protein. However, recently studies have elucidated the role of 
ATM kinase in the cytoplasm, particularly in insulin signaling.  ATM kinase activity 
increases on insulin stimulation, which further brings about complete activation of AKT 
on S473 as well as phosphorylates 4E-BP1(repressor of mRNA translation) (Boehrs et 
al., 2007; Viniegra et al., 2005b; Yang and Kastan, 2000).  On stimulating the MEFs 
expressing PP2A-Aα (WT, S401A or S401D) with insulin, the phosphomimetic mutant 
displayed elevated p-AKT (S473) levels.  This observation was in line with our 
hypothesis: insulin stimulation would increase ATM kinase activity followed by 
inhibitory phosphorylation of PP2A-Aα, resulting in increased p-AKT levels (Fig. 2-2). 
The phosphomimetic PP2A-Aα here represents the inhibited or inactive form of PP2A.  
 
AKT is a key player in some of the major signaling pathways, which are activated in 
response to insulin or by growth factors. Being known as a pro-survival molecule, one of 
its major functions is to control cell survival and cell growth (Brazil and Hemmings, 
2001). Also, we have seen that ATM inhibition by KU-60016 reduces glioma cell growth 
in vitro (Golding et al., 2009). In our study, the MEFs expressing PP2A-Aα S401D grow 
at an increased rate relative to WT and S401A expressing cells.  Interestingly, instead of 
increased basal p-AKT levels, the S401D cells expressed much higher basal p-ERK1/2 
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levels. This observation was not in line with our initial thought process, that increased 
growth signaling in MEFs would correspond to the increased basal p-AKT levels.  
 
One possible reason for increased p-ERK1/2 levels in S401D cells could be negative 
regulation of MAP kinase pathway by PP2A. PP2A can both negatively as well as 
positively regulate MAP kinase pathway by acting at different levels and on variety of 
substrates. Studies have shown that PP2A can dephosphorylate MEK1/2 and ERK1/2 and 
downregulate MAP kinase signaling (Sontag et al., 1993a; Westermarck et al., 1998). 
PP2A also acts on upstream regulators of the pathway such as, Shc, to which it binds and 
prevents signal progression (Ugi et al., 2002). Another possibility may be that the 
elevated pERK can negatively feed into PI3K pathway. Activated ERK can 
phosphorylate GAB1 and inhibit GAB1/PI3K association, which will inhibit the 
downstream AKT activation (Lehr et al., 2004) (Fig. 2-9).  
 
So far we have established that ATM phosphorylates PP2A at S401. This single site 
modification can further regulate growth signaling via PI3K or MAP kinase pathway. We 
have yet to look at other growth signaling pathways like mTOR. More thorough studies 
are required to identify specific substrates of PP2A in these signaling pathways. 
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Figure 2-9: Crosstalk between AKT/PI3K and MAP kinase pathway 
 
The figure shows cascade of activation of PI3K kinases via IRIS-1 post insulin 
stimulation as well as activation of the MAP kinases ERK1/ERK2 mediated by growth 
factor binding to receptor tyrosine kinases leading to activation of AKT and ERK 
respectively. PP2A exerts negative as well as positive control on both the pathways. 
Cross talk between these pathways exist via AKT mediated RAF inhibition as well as 
ERK mediated GAB-PI3K inhibition.  
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CHAPTER 3: 
 
Role of p-PP2A-Aα (S401) in DNA damage 
response and DSB repair 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
52 
 
 
Introduction 
 
 
 
Cells are constantly under stress due to DNA damage caused by endogenous or 
exogenous sources. In response the cell elicits a signaling cascade, commonly referred to 
as DNA damage response (DDR) to maintain genomic integrity, which is facilitated by 
regulation of DNA repair processes, cell cycle arrest, pro-survival signaling, apoptosis as 
well as senescence. The response is initiated by sensor or mediator proteins like ATM 
kinase, which form large complexes at the sites of double strand breaks (DSBs). 
Alongside, a plethora of posttranslational modifications is induced on proteins at the sites 
of damage to set the stage for checkpoint activation and DNA repair. The signal is then 
transduced to effector proteins which regulate downstream pathways like cell survival 
and apoptosis (Shiloh and Ziv, 2013).  
 
 
The phosphorylation network initiated, as a part of DDR by primary kinases like ATM, 
ATR and DNA-PK, is further amplified by checkpoint kinases Chk1 and Chk2. This 
phosphorylation cascade has to be counteracted to set the cell to normalcy and 
phosphatases play a crucial role in this process. For example, PP2A regulates both the 
primary kinases (ATM, ATR and DNA-PK) (Douglas et al., 2001; Goodarzi et al., 2004; 
Li et al., 2007; Petersen et al., 2006) as well as the secondary kinases (Chk1 and Chk2) 
(Dozier et al., 2004; Freeman et al., 2010; Leung-Pineda et al., 2006; Li et al., 2007). 
PP2A can enhances DNA-PK activity (Douglas et al., 2001) whereas it maintains ATM 
in inactive form (Dozier et al., 2004; Goodarzi et al., 2004).  
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ATM kinase is the master regulator of DDR activated post DSBs and is localized at sites 
of DNA damage. One of the first proteins to be modified following DSB induced 
response is H2AX, one of the histone variants in eukaryotic cells. H2AX is 
phosphorylated by ATM and /or DNA-PK at S139 (Rogakou et al., 1998, 1999). This 
event happens within minutes of the damage. Tanya Paull’s group and others 
demonstrated that γ-H2AX localized at the sites of DNA damage form discrete foci and 
comprise repair factors like MRN repair complex, 53BP1, BRCA1 and MDC1 (Goldberg 
et al., 2003; Paull et al., 2000). Once the repair has been initiated γ-H2AX has to be 
eliminated from the foci. Chowdhury et al., 2005 identified PP2A as an enzyme that 
regulates the kinetics of γ-H2AX at the damage foci. They demonstrated that 
dephosphorylation of γ-H2AX facilitates efficient DSB repair.   
 
PP2A also regulates the cell cycle in various stages.  It plays an important role in the 
G1/S transition by regulating the Retinoblastoma tumor suppressor protein (Rb) pocket 
family proteins. Rb is major regulator of the G1/S checkpoint. The Rb pocket proteins 
when phosphorylated by the cyclin/CDK enzymes, release the E2F transcription factors, 
which cause the expression of E2F response genes. This S phase induction by Rb proteins 
commits the cells to DNA synthesis. (Wlodarchak and Xing, 2016). Hence, regulation by 
phosphatases is essential at this stage. PP1 and PP2A both regulate Rb proteins; PP1 after 
mitosis whereas PP2A throughout the cell cycle. PP2A-B55 can bind and 
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dephosphorylate Rb p107 and cause cell cycle arrest (Kolupaeva et al., 2013), whereas 
PP2A-PR70 regulates p130 (Purev et al., 2011; Soprano et al., 2006).   
Once the cell has committed to begin DNA synthesis in the S phase, the origin replication 
complex (ORC) assembles at the origin of replication. The DNA only needs to be 
replicated once; hence, regulation of S phase proteins is extremely crucial. Cell division 
control 6 protein (Cdc6) binds to the ORC proteins and sets a stage for recruitment of 
replication machinery. PP2A ensures that a single origin is fired only once by 
dephosphorylating Cdc6 on its N-terminal region and marking it for ubiquitin mediated 
proteasomal degradation (Wlodarchak and Xing, 2016).  
 
PP2A acts at mitotic entry as well as mitotic exit. Prior to mitotic initiation, PP2A-B56δ 
dephosphorylates CDC25 at T138 and keeps it inactive and sequestered in the cytoplasm 
(Margolis et al., 2006a).  At the end of G2 phase, CDK2-mediated phosphorylation 
activates CDC25, which subsequently activates CDK1 leading to mitotic progression 
(Margolis et al., 2006b). Also, several studies have pointed out that Greatwall kinase 
mediated inhibition of PP2A facilitates CDK1 activation, which subsequently promotes 
mitotic entry (Burgess et al., 2010; Castilho et al., 2009; Lorca et al., 2010; Vigneron et 
al., 2009). Endosulfine-α (ENSA) and c-AMP-regulated phosphoprotein -19 (ARP-19) 
are phosphorylated by Greatwall kinase, following which ENSA and ARP-19 bind B56δ 
subunit of PP2A resulting inhibition of PP2A-B56δ (Gharbi-Ayachi et al., 2010; Mochida 
et al., 2010).  
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During mitosis PP2A is critical in regulation of various cellular organization events.  
Condensin I and Condensin II have an important function in mitotic chromosomal 
condensation (reviewed in Hagstrom and Meyer, 2003).  PP2A targets condensins to the 
chromosomes and for this process its phosphatase activity is not essential (Takemoto et 
al., 2009). PP2A also counteracts the Aurora B-mediated phosphorylation on 
kinetochore-associated substrates, which causes kinetochore-microtublule destabilization 
(Foley et al., 2011; Welburn et al., 2010). Plk1-mediated phosphorylation on BUBR1, 
facilitates the recruitment of PP2A-B56δ to the kinetochores, possibly resulting in 
stabilization of the kinetochore-microtuble interactions (Suijkerbuijk et al., 2012).  In 
mammalian cells, a shugoshin 1 (Sgo-1) protects the centromeric cohesin. Cohesins are 
present on the centromeres during mitosis for correct mitotic spindle assembly (Salic et 
al., 2004; Tang et al., 2004). Previous studies have suggested that PP2A holoenzymes are 
recruited to the centromeres by Sgo1, where they counteract the Plk1 and Aurora B 
mediated phosphorylation on cohesins (reviebed in Barr et al., 2011). This prevents 
premature separation of sister chromatids. PP2A-mediated dephosphorylation of the 
Golgi matrix protein induces Golgi reassembly during mitotic exit (Lowe et al., 2000; 
Schmitz et al., 2010).  Both PP1 and PP2A are implicated in controlling mitotic exit 
(Forester et al., 2007; Grallert et al., 2015; Mochida et al., 2010; Wu et al., 2009). 
Furthermore, PP2A-B55 dephosphorylates CDC25, leading to CDK1 inactivation and 
eventually exit from mitosis (Forester et al., 2007). In retrospect, PP2A acts as a mitotic 
gatekeeper.  
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Given this extensive role of PP2A in regulation of DDR proteins as well as in mitosis, it 
is evident that any dysregulation can lead to genomic instability. The DDR proteins have 
to be regulated efficiently for DNA repair proficiency. Failure to do so can cause 
improper DNA repair, leading to increased radiosensitization and other deleterious 
effects like mitotic catastrophe. 
 
Herein, we investigated how does ATM-mediated phosphorylation on the S401 site of 
PP2A-Aα affect DNA damage response, mitosis and DNA repair. We have shown that 
there are severe defects in DDR proteins as well as mitotic regulation in the constitutively 
phosphorylated mutant, S401D, as well as the S401A mutant, which cannot be 
phosphorylated.  Phosphorylation of the S401 site of PP2A- Aα also controls DNA 
repair, as we observed that DSB repair was significantly impaired in these two mutants. 
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Materials and methods 
 
Plasmids 
For end-joining repair assay: pcsCMV:tdTomato (Addgene #30530) plasmid was 
linearized with BamHI, and  a linker (5′-GATCTCCCGGGA-3′) was added at this site to 
generate a SmaI restriction site. This modified pcsCMV: tdtomato was linearized with 
BamHI and SmaI to create incompatible DNA ends.  
For DR-GFP assay: DR-GFP plasmid (Pierce et al., 1999) was used.  
 
Antibodies  
Antibodies used in western blots were anti-AKT (1:1000) (Cell Signaling Technology), 
anti-p (S473) –AKT (1:1000) (Cell Signaling Technology), anti-p(S139)- H2AX (1:1000) 
(EMD Millipore), anti-53BP1(1:1000) (Novus Biologicals) and anti-PP2A-A (1:1000) 
(Cell Signaling Technology). 
 
Cell Culture  
MEFs expressing PP2A-Aα were maintained as described in Chapter 2.  
 
 
Generation of MEFs with DR-GFP cassette:  
The FVB MEFs were infected with the DR-GFP plasmid (Pierce et al., 1999) and then, 
cell selected for puromycin resistance. The stable clonal cell lines were infected with the 
retrovirus: Mig-Aα-WT, S401A or S401D. The endogenous PP2A-Aα was floxed out by 
expression of Cre combinase (Ad-Cre).  
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Irradiation  
Irradiation was performed using MDS Nordion Gammacell 40 irradiator with the Cs-137 
source at a dose of roughly 1.05 Gy/min. 
 
 
Western blotting 
Western Blotting was performed as described in Chapter 2. 
 
Clonogenic survival assay 
MEFs expressing PP2A-Aα (WT/S401A/S401D) grown to 80% confluency in a 6 cm 
dish were trypsinized to generate single cell suspensions and cells were seeded in 60 mm 
dishes at cloning densities. Cells were allowed to attach and were either left untreated or 
irradiated at 1, 2 and 5 Gy. Cells were then incubated at 37°C and 5% CO2. After 10 
days, the media was removed and the cells were stained with 0.5% crystal violet in 25% 
methanol and colonies were counted.  
 
Transfection 
Transfections for the end-joining repair assays were done using Amaxa Nucleofector. 
(Program: N-024). MEFs expressing PP2A-Aα (WT/S401A/S401D) were transfected 
with linearized modified pcsCMV-td-tomato. (Transfection buffer recipe: Solution I: 
20% ATP-disodium salt, 12% MgCl2 (filter sterilize). Solution II:  2% KH2PO4, 2% 
NaHCO3, 0.06% glucose (filter sterilize and adjust pH to 7.4).  Just before use, solution I 
and solution II (1:50) were mixed. Use 100 μM for each transfection (Vriend et al. 2014).  
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End-joining repair assay  
A 6 cm dish (almost confluent) was trypsinized. 1 μg of DNA (linearized pcsCMV: 
tdTomato plasmid) was transfected in these cells and the cells were split into a 12 well 
dish.  Cells were collected (at 4, 8 and 16 hours). Unlinearized plasmid was used as a 
control and harvested at 24 hours. Red cells were counted using the Nexecelom 
Cellometer. For the PCR assay, post transfection as described above, cells were harvested 
at 1 and 4 hours. The media was collected from the wells, and then spun down. The 
remaining cells in the well were trypsinized and pooled with the pellet from previous 
step. The pellet was then re-suspended in re-suspension buffer (15% sucrose, 50 mM 
Tris, 25 mM EDTA) with 0.1% triton X-100 and treated with RNAse. Theses tubes were 
incubated at 50°C for 3-4 hours. Equal amount of re-suspension buffer was added with 
0.1% SDS and 50 μg/ml Proteinase K. Samples were incubated at 60°C overnight. This 
was followed by phenol chloroform treatment and DNA was precipitated with 1: 1 iso-
propanol. Repaired DNA was assessed by quantitative Real-time PCR, using an ABI 
7900HT (Applied Biosystems) and SYBR green detection. 
 
Flow cytometry 
MEFs expressing PP2A-Aα (WT, S401A or S401D) and the DR-GFP cassette were fixed 
with 100% methanol and permeabilized in 1% Triton X. Cell cycle distribution were 
analyzed by 7-aminoactnomycin D (7-AAD). Flow cytometry was done on a BD 
Biosciences FACS Canto flow cytometer at the VCU Flow cytometry. Data was analyzed 
using FCS Express software. 
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Confocal Microscopy 
Cells were grown in chamber slides (Lab-Tek -Naperville, IL) to 80-90% confluence. 
Cells were fixed with 4% paRAFormaldehyde for 15 minutes, washed with PBS 4 times 
for 5 minutes. Cells were permeabilized with 0.5% Triton X-100 in PBS and blocked 
with Casein/2% goat serum. Primary antibody incubation was performed at 4°C 
overnight.  Slides were then washed with PBS 4 times for 5 minutes and incubated with 
secondary antibody (dilution 1:500) at room temperature for 2.5 hours. The nuclei were 
counterstained with DAPI (1 mg/ml) and were mounted in Vectashield mounting media 
(Vector Laboratories). Imaging was performed using Zeiss LSM 710 Meta Imaging 
system in the VCU microscopy Facility and analyzed using the Zeiss Zen software as 
well as PERKinElmer’s Volocity software.  
 
Live – Cell Imaging 
MEFs expressing PP2A-Aα (WT/S401A/S401D)/H2B-mCherry were seeded on a 4 
chamber glass bottom CELL view tissue culture dishes (Greiner Bio-One) and allowed to 
grow until 80% confluency.  Treatment group was irradiated at 5 Gy. Still images were 
taken at every 7 minutes for a total of 16 hours beginning 1 hour after irradiation. Cells 
were kept on an incubated stage at 37°C and 5% CO2 throughout the imaging duration. 
Live cell imaging was performed on Spinning Disc Confocal Microscope at VCU 
Microscopy Facility. Videos were analyzed using Zeiss Zen software.  
Statistics  
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Unpaired two-tailed t tests were performed on triplicate or more data sets using Graphpad 
Prism 3.0 (Graphpad Software, inc.). P values are indicated as *, <0.05; **, <0.01; and 
***, <0.001. 
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Results 
 
MEFs expressing PP2A-Aα S401D show sustained γ-H2AX phosphorylation but no 
significant effect on p-AKT 
 
 
ATM kinase is a key molecule that facilitates DDR. In response to DSBs caused by 
ionizing radiation, ATM phosphorylates a large number or targets at specific positions as 
a cellular response to DSBs. ATM phosphorylates histone H2AX at S139 (γ-H2AX) in 
response to DNA damage at the sites of DSBs where they form discrete foci. 
Furthermore, PP2A mediates DSB repair via dephosphorylation of γ-H2AX to reverse 
chromatin accessibility (Chowdhury et al., 2005). To test if phosphorylation of PP2A-A 
at S401 would affect γ-H2AX levels, we looked at the γ-H2AX levels in response to low 
dose radiation. PP2A-Aα KO MEFs, expressing PP2A-Aα WT, S401A or S401D 
mutants, were irradiated at 2 Gy. In the WT cells, γ-H2AX peaked at 15 minutes before 
declining at around one hour. γ-H2AX phosphorylation was partially inhibited in the cells 
expressing the S401A mutant, whereas it continued to increase in the S401D expressing 
cells at around 60 minutes (Fig. 3-1A and 1B). We looked at γ-H2AX foci formation in 
these cells post DNA damage by immunocytochemistry. The S401D cells exhibited 
significantly higher number of foci per cell after 5 hours relative to the WT and S401A 
cells (Fig. 3-2A and 1B). This data is indicative of the S401D mutant form having less 
activity towards γ-H2AX dephosphorylation. Since ATM also regulates the  
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Figure 3-1: Sustained γ-H2AX but not p-AKT were seen in the PP2A-Aα S401D 
MEFs post IR 
 
(A) PP2A-Aα KO MEFs (WT, S401A or S401D) were exposed to 2 Gy of ionizing 
radiation and harvested after 5, 15, 30 and 60 minutes. p-AKT (S473), total AKT and γ-
H2AX levels were detected by western blotting. (B & C) p-AKT levels were normalized 
to total AKT protein levels. γ-H2AX levels were normalized to GAPDH. 
A 
B
 
C 
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Figure 3-2: S401D MEFs had sustained γ-H2AX levels post IR 
 
(A) PP2A-Aα KO MEFs (WT, S401A and S401D) were exposed to 5 Gy of ionizing 
radiation or left un-irradiated and fixed after 0.5 and 5 hours. γ-H2AX foci in at least 30 
cells were counted for each group. Error bars SEM n = 3, ***p < 0.001 relative to WT 
(B) Representative images of cells immunolabeled with γ-H2AX antibody (Red) and 
counterstained with DAPI (Blue) to label nuclei, Images were acquired at 63x power. 
A 
B
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phosphorylation of AKT (S473) in response to IR (Golding et al., 2009; Viniegra et al., 
2005a), we assessed the levels of  p-AKT (S473) post IR treatment. Time-dependent 
increase in AKT phosphorylation was seen as early as 5 minutes in the WT-PP2A-Aα 
KO MEFs (Fig. 3-1C). However, this increase was abrogated in the cells expressing 
S401A and S401D, suggesting that PP2A-Aα phosphorylation at S401 may not regulate 
p-AKT (S473) in response to IR.  
 
Improper phospho-regulation at S401 site of PP2A-Aα leads to abnormal mitoses 
 
 
PP2A holoenzyme has a distinct function in different phases of mitosis by associating 
with the respective B subunits. Mitotic entry is promoted by inhibition of PP2A via 
Greatwall kinase (Vigneron et al., 2009; Lorca et al., 2010).  During mitosis PP2A 
holoenzyme with specific B’ subunits are recruited at the centrosomes along with Sgo-1, 
where they play a critical role in protecting centromeric cohesins by inhibiting Plk1 and 
Aurora A kinases (Hauf et al., 2005; Kitajima et al., 2006; Riedel et al., 2006). PP2A also 
controls mitotic exit along with PP1 (Forester et al., 2007; Grallert et al., 2015; Mochida 
et al., 2010; Wu et al., 2009).  Taking into account the extensive role of PP2A in mitosis, 
we examined mitosis in PP2A-Aα KO-MEFs (WT/S401A/S401D). We performed live 
cell imaging in these cells labeled with histone H2B-mCherry construct that aided us in 
visualizing dividing nuclei. The WT cells underwent normal mitosis in the absence of IR- 
induced DNA damage. The S401A and S401D cells exhibited abnormal mitoses  
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Figure 3-3: S401A and S401D cells under go aberrant mitosis 
 
Time series of mitosis in PP2A-Aα KO MEFs (WT, S401A and S401D) /H2B-mCherry 
cells. Cells were exposed to 5Gy of IR and subjected to live-cell video imaging. 
Representative still images of cells undergoing aberrant mitosis are shown.  
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Figure 3-4: S401A and S401D MEFs undergo prolonged mitosis and accumulate 
increased chromosomal aberrations   
 
(A) Length of mitosis was measured in untreated PP2A-Aα KO MEFs (WT, S401A and 
S401D)/H2BmCherry cells. (B&C) PP2A-Aα KO MEFs (WT, S401A and S401D) were 
irradiated at 5Gy, fixed after 24h. Mitotic index was calculated as the ratio of mitotic 
cells to the total number of cells. Aberrations were scored as total number of micronuclei, 
bridges and abnormal metaphase plates relative to the total number of nuclei. At least 200 
cells were counted for each group. SEM; n = 3, ***p < 0.001, **p< 0.01 and *p<0.05 
relative to WT.  
A 
B 
C 
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including formation of micronuclei and tetraploidy whose frequency increased on 
exposure to IR. Most of the mutant cells suffered mitotic catastrophe (Fig. 3-3). In 
undamaged cells, the length of mitoses in the S401A and S401D cells was significantly 
longer thanthe WT (Fig. 3-4A). Additionally, we measured the mitotic index (ratio of 
cells undergoing mitoses to the total number of cells) and chromosomal abnormalities 
after exposure to IR. As predicted, the mitotic index in the WT cells decreased but not in 
the S401A and S401D cells (Fig. 3-4A), suggesting a deficiency in checkpoint activation 
in the mutants. Furthermore, relative to WT cells the S401A and S401D had significantly 
increased numbers of chromosomal aberrations (Fig. 3-4B and 4C). All these data 
suggest that the S401 site of PP2A-Aα plays an important role in mitotic regulation.  
 
 
MEFs expressing PP2A-Aα S401D and S401A displayed increased 
radiosensitization 
 
DDR activity is protective towards the cell in an event of DNA damage. It upregulates 
DNA repair in order to protect the cell from genomic instability. Dysregulation of DDR 
and genomic instability can often lead to radiosensitization of cells. ATM kinase 
regulates DSB repair as well as controls cell cycle checkpoints; therefore inhibition or 
loss of ATM kinase increases radiosensitivity (Lavin, 2008; Valerie and Povirk, 2003). 
We are studying the regulation of PP2A by ATM. Our mitosis data suggested a possible 
role of the S401 site of PP2A-Aα in cell cycle and mitotic regulation. Therefore we  
69 
 
 
                
Figure 3-5: S401D MEFs display increased radiosensitization  
 
PP2A-Aα KO MEFs (WT, S401A and S401D) were irradiated at 1, 2 and 5Gy and 
radiosurvival was determined after 10days. Survival fractions were determined by crystal 
violet staining and colony counting. Data points, surviving cells plotted as fraction of 
control (- irradiation). Error bars SEM; n=4. S401D is significantly different from WT 
,p< 0.05. 
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performed a clonogenic survival assay in PP2A-Aα KO MEFs (WT, S401A and S401D). 
We observed that the S401A and the S401D cells were more radiosensitive relative to 
WT, the S401D being significantly impaired in radiosurvival. (Fig. 3-5).  This suggests 
that the irregular phosphorylation at S401 of PP2A-Aα can result in checkpoint 
deficiencies causing build up of genomic instability, which can result in increased 
radiosensitivity. 
 
 
Inappropriate phosphorylation at S401 of PP2Aα leads to inefficiency in DSB repair  
 
 
PP2A has known function in maintaining genomic stability by modulating proteins 
involved in DNA repair. PP2A is involved in the NHEJ pathway of DSB repair, where it 
facilitates DNA end joining by dephosphorylation and subsequent activation of KU and 
DNA-PKcs. These proteins are major players of NHEJ (Wang et al., 2009). Increased 
chromosomal aberrations in the MEFs expressing S401A and S401D mutants suggest 
inefficient DNA repair post damage, the accumulation of which could lead to mitotic 
catastrophe. To determine how the phosphorylation of PP2A-Aα at S401 might affect 
DSB repair, we performed an in vivo as well as in vitro end-joining assay. PP2A-Aα KO 
MEFs expressing WT, S401A and S401D mutants were transfected with pCSCMV: 
tdTomato plasmid linearized with BamHI and SmaI to create a 5’-overhang and blunt end 
that cannot easily be ligated without DNA resection and DSB repair. Once the plasmid is 
repaired and circularized; red fluorescence protein (RFP) will be expressed (Fig. 3-6). 
Cells were collected at various time points and RFP+ cells were quantified. At  
71 
 
 
                        
 
 
Figure 3-6: Scheme for in vitro end joining assay 
 
PP2A-Aα KO MEFs (WT, S401A and S401D) were transfected with BamHI/SmaI 
linearized pCSCMV: tdTomato. 
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Figure 3-7: S401D MEFs were inefficient in end-joining mediated repair 
 
(A) Cells were collected after 4, 8 and 16 hours and RFP positive cells were quantified. 
Supercoiled pCSCMV: tdTomato was used as transfection control. (B) PCR assay: Cells 
were collected after 1 and 4 hours. Plasmid DNA was isolated and the repaired DNA was 
quantified by Real time PCR. SEM; n = 3, ***p < 0.001, **p< 0.01 and *p<0.05 relative 
to WT. 
A 
B 
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Figure 3-8: S401A and S401D cells show sustained 53BP1 foci 
  
(A) PP2A-Aα KO MEFs (WT, S401A and S401D) were exposed to 5 Gy of ionizing 
radiation or left un-irradiated and fixed after 0.5 and 5 hours.  Cells with more than 5 
53BP1 foci were counted for each group. Error bars SEM n = 3, ***p < 0.001 relative to 
WT (B) Representative images of cells immunolabeled with 53BP1 antibody (Green)γ-
H2AX antibody (Red) and counterstained with DAPI (Blue) to label nuclei, Images were 
acquired at 63x power. 
A 
B 
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16 hours the S401A-PP2A-Aα KO MEFs had almost twice the number of red cells 
relative to the WT cells, whereas the S401D cells had less than the WT cells (Fig. 3-7A). 
In a different experiment with the same set up, cells were harvested after 1 and 4 hours, 
plasmid DNA was isolated, and end-joining was quantitated by real-time PCR.  
Consistent with the previous assay, the S401D cells were significantly deficient in end 
joining (Fig. 3-7B).  We also looked at the DDR factor tumor suppressor 53BP1,which 
promotes c-NHEJ and suppresses repair via HRR. We saw that the S401D mutant had 
sustained 53BP1 foci, which co-localized with γ-H2AX foci (Fig. 3-8A & B). The 
S401A MEFs also had few bigger foci at 5 hours (Fig. 3-8B). 
 
Since multiple pathways repair DSBs, we looked at HRR efficiency in these cells. PP2A 
holoenzyme associated with B55 subunit has been implicated in regulation of 
homologous recombination repair (HRR) via modulation of ATM phosphorylation and 
the G1/S check point (Kalev et al., 2012). To determine the importance of ATM mediated 
phosphorylation of PP2A-Aα in HRR, we expressed DR-GFP repair reporter (Beckta et 
al., 2015) in the PP2A-Aα CKO/CKO MEFs. These cells were infected with Mig-Flag-
Aα-WT, S401A and S401D retrovirus and the endogenous PP2A-Aα was floxed out with 
an Adenovirus expressing Cre recombinase.  To measure HRR, DSBs were induced by 
adenoviral-mediated expression of I-SceI enzyme, which cleaves the DR-GFP gene; 
HRR at this break will restore WT-GFP expression. 72 hours post infection with Ad-
SceI, the cells were processed and analyzed to count GFP expressing cells by flow 
cytometry. We observed that the number of GFP cells in S401A and S401D were  
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Figure 3-9: S401A and S401D MEFs are impaired in HRR 
 
(A) Scheme for DR-GFP assay. (B) PP2A-Aα KO MEFs (WT, S401A and S401D) 
expressing the DR-GFP cassette were infected with Ad-SceI, 72 hours post Ad-SceI 
infection, 30000 cells were analyzed for GFP (HRR) events using flow cytometry.  
SEM; n = 3, *p<0.05 relative to WT. 
 
A 
B 
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Figure 3-10: Representative histograms for DR-GFP assay 
 
Representative histograms from uninfected control and infected (Ad-SceI) for PP2A-Aα 
KO MEFs ( WT, S401A and S401D) from one single experiment are shown.  
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significantly less than the WT. This data suggests that in the cells expressing the mutant 
proteins, there was significant reduction in HRR (Fig 3-9 and 3-10). 
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Chapter summary 
 
 
Of all the DNA lesions, DSBs are the most lethal ones. Failure to repair DSBs correctly 
can lead to increased genomic instability like chromosomal breaks and translocations that 
have the potential to cause oncogenic transformations (Goldberg et al., 2003; Stucki et 
al., 2005). Reversible phosphorylation is an extremely important posttranslational 
modification of proteins, and plays a crucial role in many cellular events including DDR. 
Kinases and phosphatases work together to regulate this signaling cascade in response to 
specific molecular cues.  
 
As discussed earlier, it is well established that ATM is a master regulator of DDR, and 
PP2A is required for IR-induced activation of ATM.  Activated ATM phosphorylates and 
recruits γ-H2AX at the sites of DSBs, which further recruits DNA repair proteins on 
chromatin adjacent to the DSBs (Xu et al., 2012; Melander et al., 2008; Stucki et al., 
2005; Fernandez-Capetillo et al., 2002; Paull et al., 2000; Rogakou et al., 1998).  The 
dissociation of the repair proteins from the DSBs requires elimination of γ-H2AX from 
the DSBS. This is important for checkpoint recovery (Keogh et al., 2006). One of the 
mechanisms by which this is achieved is by PP2A-mediated dephosphorylation of γ-
H2AX (Chowdhury et al., 2005).  In our study we assessed γ-H2AX induction kinetics in 
PP2A-Aα KO MEFs expressing the WT, S401A and S401D PP2A-A in response to low 
dose of IR.  In WT cells, γ-H2AX protein levels as well as foci peaked around 30 
minutes, which diminished over a period of 5 hours. However, in the S401D cells, 
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sustained γ-H2AX foci were seen at 5 hours. The γ-H2AX kinetics in S401A mutant cells 
were not significantly distinct than the WT cells, though protein levels seemed to be 
lower at earlier time points (Fig. 3-1A, B and 3-2). Recently, the Li group demonstrated 
that suppression of PP2A- B56ε leads to a delay in elimination of γ-H2AX, and presented 
a possibility that PP2A holoenzyme with the B56ε mediates the dephosphorylation of γ-
H2AX at DSBs (Li et al., 2015).  This is in line with our hypothesis that ATM-mediated 
phosphorylation at S401 of PP2A (S401D phosphomimetic) would inhibit PP2A’s 
activity leading to increased γ-H2AX levels.   
 
Also, ATM regulates AKT phosphorylation (S473) in response to irradiation (Golding et 
al., 2009; Viniegra et al., 2005b). When we looked at p-AKT (S473) levels in MEFs post 
IR, we did not see any significant difference between our mutants and the WT (Fig. 3-
1A).  Given the number of distinct regulatory subunits of PP2A, which directs it towards 
respective substrates, it is possible that ATM mediates AKT activation via PP2A by a 
mechanism different from what we have hypothesized. AKT, which is regulated by 
phosphorylation at T308 and S473, can promote cell growth or apoptosis depending on 
the signals received from the cellular environment (Andrabi et al., 2007).  
 
Impaired DDR can often lead to genomic instability and abrogated checkpoints. In the 
absence of DNA damage, the S401A and S401D PP2A-Aα spent more time in mitosis 
relative to the WT cells (Fig. 3-4A). Also, they harbored increased chromosomal 
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aberrations relative to WT in response to IR (Fig. 3-3 and 3-4C). As reviewed earlier, 
PP2A plays a wide range of roles in mitosis. It regulates mitotic entry as well mitotic exit.   
In Xenopus egg extracts, depletion of PP2A-B55δ allowed entry into mitosis but the cells 
were unable to exit mitosis (Mochida et al., 2009). This could explain the reason of 
prolonged mitosis. There are other phosphatases like PP1 that can often complement and 
allow cell cycle progression eventually. Proteins like Plk-1 and Sgo1, regulated by PP2A, 
are responsible for mitotic checkpoints. Failure of these checkpoints in presence of DNA 
damage can affect microtubule and spindle assembly leading to aberrant mitosis (Hauf et 
al., 2005; Kitajima et al., 2006). Also, deficient cell cycle checkpoints and abnormal 
chromosomes can cause mitotic catastrophe, consequently resulting in increased 
radiosensitization. PP2A is essential for IR-induced G2/M check point (Yan et al., 2010) 
and PP2A-Aα depletion via siRNA radio-sensitized pancreatic cells (Wei et al., 2013). 
The PP2A-Aα S401D mutant cells can go through G2/M transition without efficient 
DNA repair thereby resulting in increased radiosensitivity. 
 
 
DDR appeared to be dysregulated in the S401D cells due to sustained γ-H2AX levels. 
This suggested that DNA repair factors are still present at the foci and checkpoint 
recovery is possibly delayed. To validate if DSB repair is affected in these cells, we 
looked at NHEJ efficiency and HRR efficiency in PP2A-Aα KO MEFs (WT, S401A and 
S401D).  From our end-joining assay, we can conclude that the S401D mutant cells are 
extremely inept at repairing the DSBs via non-homologous end joining (NHEJ) (Fig 3-
7A and B). The DDR factor 53BP1 promotes c-NHEJ by blocking 5’ resection at DSBs, 
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which is required for HRR (reviewed in Zimmermann and Lange, 2014). 53BP1 forms IR 
induced foci that co-localize with γ-H2AX (Anderson et al., 2001; Rappold et al., 2001; 
Schultz et al., 2000). We saw that in the S401A and S401D mutants there was a delay in 
disappearance of 53BP1 foci at 5 hours. One possible reason could be slow repair 
kinetics in these mutants. The S401A mutant shows few but bigger 53BP1 foci (Fig 3-8), 
which could represent a site of complex DNA damage (Marková et al., 2007). PP2A 
elicits control on NHEJ via positively regulating Ku/DNA-PK activity required for end 
joining. PP2A-mediated dephosphorylation of Ku70/Ku86 and DNA-PKcs elevated 
DNA-PK activity in vitro and in vivo (Douglas et al., 2001; Wang et al., 2009).  
Consequently, the inefficiency of DSB end joining we observe in our study could be 
attributed to reduced activity of DNA-PK, which could slow down DNA repair via c-
NHEJ in the S401D cells.  
 
We also looked at HRR pathway, which is the other major and more efficient DSB repair 
pathway. There was significant reduction in HRR+ (GFP) cells post I-SceI infection in 
MEFs expressing the S401A and S401D mutant (Fig 3-9 and 3-10). A study by the 
Sablina group has implicated the B55 subunit in HRR where it acts via ATM and G1/S 
check point regulation (Kalev et al., 2012). Also, pharmacological inhibition of PP2A 
also inhibited HRR and accumulated IR induced DNA damage in pancreatic cancer cells 
(Wei et al., 2013). The S401A cells looked relatively proficient in NHEJ but inefficient in 
HRR. Perhaps it is possible that in the S401A cells the repair is directed from HRR to 
NHEJ. The S401D MEFs, which are deficient in both the NHEJ and HRR pathway, still 
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survive due to a very inefficient DNA repair mechanism, which leads to increase in 
genomic instability as seen in our study. 
 
The data presented in this chapter imply that ATM-mediated S401 phosphorylation of 
PP2A-Aα is an essential post-translational modification. ATM-mediated phosphorylation 
can regulate the repair kinetics in the cell. Our studies show that cells expressing S401 
mutants are inefficient in DNA repair. We have seen a significant amount of mitotic 
aberrations in these cells. Accumulation of unrepaired DNA can have deleterious effects 
on the cells, like the mitotic catastrophe seen in the S401 mutants. 
 
Interactions of PP2A with its substrates depend on specific B subunits, which further 
regulate DDR proteins. We have observed that phosphorylation at S401 causes the 
holoenzyme to dissociate from its substrates as well as the C-subunit.  The enzyme could 
undergo structural change post S401 phosphorylation thus causing this dissociation and 
thereby affecting its interaction with its substrates and regulatory subunits. Studies in the 
next chapter have helped us to deduce a possible mechanism by which the DDR could be 
regulated by ATM-mediated phosphorylation on PP2A-Aα. 
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CHAPTER 4: 
 
Phosphorylation of PP2A-Aα at S401 causes its 
nuclear export via CRM1 
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Introduction  
 
 
 
Studies have shown that phosphatases respond to DNA damage primarily by altering 
subcellular localization, which can govern substrate association and subsequently 
downstream cellular signaling. In our study, we observed that the S401D PP2A-Aα was 
cytoplasmic and the S401A was mostly nuclear, whereas the WT was both cytoplasmic 
and nuclear. This brought us to the next question. Does ATM mediated phosphorylation 
on S401 cause its translocation to the cytoplasm? 
 
There are a number of pathways by which nuclear export of a protein can take place 
(reviewed in Ossareh-Nazari et al., 2001). One of the karoypherins, chromosome region 
maintenance 1/exportin/Exp1/Xpo1 (CRM1), has been studied extensively. CRM1 binds 
to the leucine-rich nuclear export signal (NES) in many organisms (Fornerod et al., 1997; 
Fukuda et al., 1997; Haasen et al., 1999; Neville and Rosbash, 1999; Ossareh-Nazari et 
al., 2001; Stade et al., 1997). Efficient binding of CRM1 to the NES sequence, requires 
the NES to have five consensus hydrophobic residues that can be spatially coordinated 
with the NES docking site on CRM1 (Engelsma et al., 2004; Güttler and Görlich, 2011; 
Kudo et al., 1998).  CRM1-mediated nuclear export can be effectively inhibited by a 
Streptomyces metabolite, Leptomycin B (LMB) (Hamamoto et al., 1983a, 1983b, 1985). 
LMB has been shown to interact directly with CRM1, where it binds covalently to the 
cysteine residue in CRM1 (Kudo et al., 1999). This disrupts the interaction between 
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CRM1 and the NES on its target, thereby inhibiting the subsequent CRM1-mediated 
export of the target protein (Fornerod et al., 1997; Kudo et al., 1998; Nishi et al., 1994).  
 
The translocation of CRM1-mediated transport takes places across a RanGTP gradient. 
The binding of CRM1 to RanGTP in the nucleus is essential, as it provides metabolic 
energy for the directional transport (Görlich et al., 1996, 1997; Rexach and Blobel, 1995). 
The protein containing the NES forms an export complex with CRM1 and RanGTP in the 
nucleus (Fornerod et al., 1997; Fukuda et al., 1997; Görlich and Kutay, 1999; Mattaj and 
Englmeier, 1998; Stade et al., 1997). On translocation through the nuclear pore complex 
(NPC), RanGTP is hydrolyzed to RanGDP, causing irreversible dissociation of the export 
complex (Englmeier et al., 1999; Görlich and Kutay, 1999; Izaurralde et al., 1997; 
Kehlenbach et al., 1999; Mattaj and Englmeier, 1998). The export cycle is completed by 
reimport of RanGDP to the nucleus, where GDP is exchanged to GTP (Ribbeck et al., 
1998; Yi et al., 2002).  
 
The diversity of the PP2A holoenzyme is imparted to it due to the association of the AC 
core dimer with the distinct variety of B subunits (Janssens and Goris, 2001). The 
substrate specificity and the subcellular localization of the holoenzyme are governed by 
specific B-subunits. Tsuchiya et al. identified a functional NES in the PP2A-Cα subunit, 
whose disruption inhibited nuclear export of PP2A-Cα (Tsuchiya et al., 2006). Also, 
LMB treatment caused accumulation of PP2A-Cα in the nucleus in this study. In a 
following study conducted by Flegg et al., a functional NES in PP2A-B56α subunit was 
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identified (Flegg et al., 2010). LMB treatment blocked the cytoplasmic translocation of 
the PP2A-B56α. They also reported that disruption of the PP2A-B56α NES prevents the 
PP2A-Cα’s translocation to the cytoplasm, thereby concluding that PP2A-B56α 
association is important for the nuclear export of PP2A-Cα (Flegg et al., 2010). Another 
B-subunit that is also subjected to CRM1-mediated nuclear export is PP2A-B56ε (Jin et 
al., 2009). In their study, one of the PP2A-B56ε isoforms that lacked the N-terminus was 
cytoplasmic (Jin et al., 2009). Flegg et al. verified this by identifying a highly potent NES 
on the C-terminus, which clarified this observation (Flegg et al., 2010).   
 
Depending on the function of the specific PP2A holoenzyme, it possibly gets displaced in 
order to respond to cellular cues. The cytoplasmic localization of the PP2A-Aα S401D 
mutant led us to pursue localization studies in PP2A-Aα KO MEFs. We hypothesized 
that, in response to DNA damage, activated ATM kinase phosphorylates S401 of PP2A-
Aα and causes export to the cytoplasm via CRM1. Our studies indicated that PP2A-Aα 
and CRM1 indeed interact and nuclear retention of PP2A-Aα increased post LMB 
treatment. We also identified a putative NES sequence in PP2A-Aα.  
 
 
 
 
 
87 
 
 
Materials and methods 
 
Plasmids   
pFlag-hCRM1 (Addgene #17647), pmCherry-C1 Ran Q69L (Addgene #30309), 
mRuby2-PP2A-Aα : pGEX2T- PP2A-Aα (Chapter 2) was cut with BamHI and EcoRI, 
1776 bp fragment cloned into mRuby2-C1 (Addgene#54768), pPAmcherry-PP2A-Aα : 
(1. pGEX2T- PP2A-Aα was cut with BamHI and EcoRI. The 1776 bp fragment was 
cloned in pEGFP-C3-hYAP1 (Addgene #17843), linearized with BglII and EcoRI. 2. 
pPAmCherry-α-tubulin (Addgene31930) was cut with NheI and BglII, the 739 bp 
fragment was cloned in pEGFP-C3- PP2A-Aα digested with NheI and BamHI.) 
 
Antibodies 
Antibodies used in western blots were anti- Flag (1:1000) (Sigma Aldrich), anti-p(S139)-
gH2AX (1:1000) (EMD Millipore) and anti-PP2A-A (1:1000) (Cell Signaling 
Technology), Hoeschs stain 333242 (Sigma Aldrich). 
 
Cell Culture  
MEFs expressing PP2A-Aα (WT, S401A and S401D) and HEK293 cells were 
maintained as described in Chapter 2.  
 
Irradiation  
Irradiation was performed using MDS Nordion Gammacell 40 irradiator with Cs-137 
source at a dose of roughly 1.05 Gy/min. 
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Western Blotting 
Western Blotting was performed as described in Chapter 2. 
 
Immunoprecipitation 
HEK 293 cells were co-transfected with Flag-CRM1, untagged RanQ69L and mRuby2 
PP2A-Aα plasmids. 72 hours post transfections cells were lysed in NP40 buffer (50 mM 
Tris-HCl, pH 8.0, 150 nM NaCl, 1% NP40, protease inhibitor cocktail) containing 2 mM 
GTP-γ-S for 15 minutes on ice and lysates were cleared by centrifugation. The 
supernatants were incubated with anti-Flag beads in NP40 lysis buffer supplemented with 
10 mM GTP for 30-60 minutes rotating at 4°C. Beads were washed in ice-cold PBS 
containing 10Mm GTP. Proteins were eluted in Laemmli buffer and processed for 
western blotting (Maiuri et al., 2013). 
 
Confocal microscopy and live cell imaging 
Confocal imaging (described in Chapter 3) and activation of photoactivatable mCherry –
PP2A-Aα was done with a Zeiss LSM 710 Meta Imaging system in the VCU microscopy 
Facility. A 35 mW blue diode 405 nm laser was used at fairly high output (25–50% 
transmission) to target small regions in the nucleus using the photobleaching function of 
the Zeiss software in time-series mode. Around 180 pulses of the 405 nm laser were 
required to activate PAmCherry PP2A-Aα for fluorescence emission that was detected by 
excitation at 561nm. The cells were followed for 10 minutes and images and ROI 
intensities were acquired every 5 seconds. 
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Results 
 
 
Phosphomimetic mutant, S4101D of PP2A-Aα is localized to the cytoplasm in MEFs 
whereas the S401A mutant is nuclear  
 
 
Karl Herrup’s group observed that, in neurons, endogenous PP2A-A was largely 
cytoplasmic as opposed to ATM-deficient neurons, where it was primarily nuclear. They 
also demonstrated that ATM-mediated phosphorylation is responsible for altered 
localization of PP2A-A (Li et al., 2012). According to their study in neurons the S401A 
mutant of PP2A-A localized in the nucleus and the S401D mutant is localized in the 
cytoplasm. Since, we are also studying the ATM regulation on S401 site of PP2A-Aα; we 
looked at the localization of these mutants in our system, i.e., PP2A-Aα KO MEFs 
expressing the WT, S401A and S401D mutant forms. The Flag-WT PP2A-Aα was 
present in the cytoplasmic as well as the nuclear compartments. The S401A isoform was 
predominantly nuclear whereas the S401D isoform was predominantly cytoplasmic (Fig. 
4-1). Through this study we were able to recapitulate the observations made by Herrup’s 
group in neurons in our genetic system.  
 
PP2A-Aα interacts with CRM1  
 
 
Observation from our previous study shows that ATM phsphorylation on S401 PP2A-Aα 
causes it to translocate to the cytoplasm (Li et al., 2012) (Fig. 4-1). To charaterize the   
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Figure 4-1: Cellular localization of PP2A-Aα 
 
PP2A-Aα KO MEFs (WT, S401A and S401D) were immunolabeled with Flag antibody 
(Red) and counterstained with DAPI (Blue) to label nuclei, Images were acquired at 63x 
power. 
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mechanism of this nuclear export, we assesesd the protein sequence of PP2A-Aα. We 
plugged the PP2A-Aα sequence in the NetNES 1.1 server, which predicts leucine-rich 
nuclear export signals in eukaryotic proteins (Cour et al., 2004).  We got a hit for PP2A 
with a predictive sequence LLPLFL370AQL373 (Fig. 4-2A). The nuclear export signal 
(NES) consensus sequence is LxxLxL (Cour et al., 2004). The export of proteins 
harboring a functional NES sequence is facilitated by CRM1 (Fornerod et al., 1997; 
Fukuda et al., 1997; Haasen et al., 1999; Ossareh-Nazari et al., 2001). We therefore 
looked at the interaction of CRM1 with PP2A-Aα. We performed co-
immunoprecipitation in HEK293 cells expressing the Flag-CRM1, mRuby2-PP2A-Aα 
and untagged RanQ69L. The CRM1 mediated export occurs across a Ran GTP gradient, 
which is disrupted on cell lysis (Güttler and Görlich, 2011). Hence, we used the 
RanQ69L mutant that is incapable to exchange GTP for GDP (Klebe et al., 1995), which 
prevents the dissociation of the Ran-CRM1 complex in whole cell extracts. The 
immunoprecipitation experiment showed that CRM1 interacted with endogenous PP2A-
A.  Also, the predictive NES was in proximity to the S401 site of PP2A-Aα (Fig. 4-2A). 
This leads us to hypothesize that binding of CRM1 to the PP2A-Aα NES could be 
essentially influenced by the phosphorylation state at S401.  
 
PP2A-Aα export to cytoplasm post IR is blocked by Leptomycin B  
 
 
Leptomycin B is a metabolite from Streptomyces which inhibits the CRM1 nuclear export  
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Figure 4-2: PP2A-Aα binds to CRM1 
 
(A) Protein sequence of PP2A-Aα with the putative NES sequence highlighted in red. (B) 
HEK 293 cells were transfected with Flag-CRM1, mRuby2-PP2A-Aα and untagged 
RanQ69L. 72 hours post transfection, the cell extract was co-immunoprecipitated with 
Flag-CRM1 and examined for PP2A-A by western blot analysis. 
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Figure 4-3: Structure of PP2A with the Aα S401 and NES sites 
   
Crystal structure of PP2A holoenzyme (PDB: 2IAE_A), highlighting the different 
subunits, the S401 site and the putative NES sequence.  
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receptor and inhibits CRM1-dependent nuclear export (Kudo et al., 1998; Neville and 
Rosbash, 1999). The presence of  predictive NES in PP2A-Aα and its interaction with 
CRM1 indicated that CRM1 could mediate PP2A-Aα nuclear export. To validate this 
further, we treated PP2A-Aα KO MEFs expressing the WT form with Leptomycin B for 
30 and 60 minutes. We observed that Flag- PP2A-Aα-WT started accumulating in the 
nucleus post leptomycin B treatment (Fig. 4-4A). We also looked at the localization of 
PP2A-Aα-WT post irradiation in presence and absence of leptomycin B. On exposure to 
irradiation, Flag-PP2A-Aα was chiefly cytoplasmic after 60 minutes. When the cells were 
treated with leptomycin B prior to irradiation, this translocation was inhibited. We saw 
that treatment with leptomycin B prevented IR-induced translocation of PP2A-Aα to the 
cytoplasm (Fig. 4-4A). These results suggest that, DNA damage caused by ionizing 
radiation promotes the translocation of PP2A-Aα to the cytoplasm via CRM1. 
 
Monitoring translocation of PP2A-Aα using photoactivatable fluorescent proteins 
 
 
Our data so far suggests that DNA damage triggers trranslocation of PP2A-Aα to the 
cytoplasm possibly after ATM-mediated phosphorylation at S401. To visualize the 
translocation of PP2A-Aα in real time, we explored the photo activation system, which 
has been extensively used to follow intracellular proteins over a period of time. We used 
the PAmCherry vector. PAmCherry is originally non-fluorescent but when exposed to 
350-400 nm light, emits red fluorescence (Subach et al., 2009) (Fig. 4-5A). We cloned  
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Figure 4-4: PP2A-Aα is exported to the cytoplasm post IR 
 
(A) PP2A-Aα KO MEFs (WT, S401A and S401D) were treated with Leptomycin B 
(2ng/ml) alone for total of 6 hours. For irradiation treatment, cells were exposed to 10Gy 
and fixed after 30and 60minutes, The cells were immunolabeled with Flag antibody 
(Red) and counterstained with DAPI (Blue) to label nuclei, Images were acquired at 63x 
power. (B) Schematic representation of PP2A-Aα export post irradiation. 
A 
B
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PP2A-Aα in the PAmCherry vector and transfected PAmcherry-PP2A-Aα in HEK293 
cells. 48 hours post transfection the cells were set incubated stage at 37°C and 5% CO2. 
A region in the nucleus was activated using the 405 nm laser line and fluorescence was 
detected at 561 nm.  We also performed this experiment on cells pretreated with a DNA 
intercalating agent, Hoechst dye (Kong et al., 2009) which sensitizes cells to DNA 
damage.  In our preliminary experiments we observed that PAmCherry-PP2A-Aα is 
activated in the nucleus. In the Hoechst treated cells there seems to be translocation of 
PP2A-Aα to the cytoplasm faster than the untreated (Fig. 4-5B). However, more 
experimental repeats are required to make any final remarks. We confirmed by γ-H2AX 
staining that Hoechst pretreatment caused DNA damage (Fig. 4-6).  
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Figure 4-5: Photo activation of PAmCherry-PP2A-Aα 
 
(A) Schematic representation for mechanism of photoactivation of PAmcherry-PP2A-Aα. 
(B) HEK 293 cells were transfected with PAmCherry-PP2A-Aα. 48 hours later 
PAmcherry-PP2A-Aα was activated by 405nm laser in the nuclear region (yellow boxes) 
and the red fluorescent PP2A-Aα was monitored over a time period.  
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Figure 4-6: Hoechst treatment causes DNA damage  
 
HEK 293 cells were transfected with PAmCherry-PP2A-Aα. 48 hours later PAmcherry-
PP2A-Aα was activated by UV light and fixed after 30 minutes. The cells were 
imunolabeled with γ-H2AX antibody.  
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Chapter summary 
 
 
 
Li et al looked at the localization of PP2A-Aα WT, S401A and the S401D mutant in 
neurons. According to their study, WT PP2A-Aα is nuclear and cytoplasmic and  S401A 
was nuclear, whereas S401D was cytoplasmic (Li et al., 2012).  In line with their 
observations, our genetic model system behaved similarly: the WT PP2A-Aα is nuclear 
and cytoplasmic; S401A was nuclear, whereas S401D was cytoplasmic in the PP2A-Aα 
KO MEFs.   
 
At this point we know that B56α, B56ε and the Cα subunits harbor the NES. However, at 
this stage we are not aware which B subunit is associated with the PP2A holoenzyme, 
and acting downstream to ATM. Since the molecular modeling studies (Chapter 2. data 
not shown) suggest that the S401 phosphorylation causes distortion in the horseshoe 
shape of PP2A-Aα, we checked if PP2A-Aα has a NES.  The NetNES 1.1 Server 
predicted the LLPLFL370AQL373  as a putative NES sequence (Cour et al., 2004). 
Classically, the NES is comprised of short peptides comprising four spaced hydrophobic 
residues  (denoted Φ1–Φ4) and to follow the consensus Φ1-(x)2–3-Φ2-(x)2–3-Φ3-x-Φ4, 
where x is an charged or a polar amino acid (Kutay and Güttinger, 2005). Although the 
PP2A-Aα NES does not directly fit the classical NES consensus, Güttler et al. 
demonstrated that CRM1 can recognize diverse NESs that differ from the consensus 
(Güttler et al., 2010).  Although the NES is referred to as leucine-rich, several proteomic 
screens have revealed that the leucine can be replaced by isoleucine, valine, methionine 
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or phenylalanine at hydrophobic positions (Kosugi et al., 2008; Yi et al., 2002; Zhang and 
Dayton, 1998). Also, when we looked at the position of the putative NES relative to the 
S401 residue on PP2A-Aα, they looked proximal. Based on this we speculated that 
phosphorylation on S401 could affect the NES affinity to CRM1. We plan to mutate the 
Leucine373 of this putative NES to Alanine and verify the functionality of this region with 
respect to nuclear export. 
 
Our immunoprecipitation data shows that PP2A-A and CRM1 interact. Dr. Mostafa 
Ahmed, who helped us with modeling studies in Chapter 2, also helped us to study 
PP2A-Aα binding with CRM1 in silico. The modeling studies (Data not shown) revealed 
that the WT, S401A and the S401D have different affinities to CRM1. The HINT 
(Hydropathic INTeractions) score (Kellogg et al., 1991) which relates to the affinity 
between two proteins, was highest for the S401D mutant followed by the WT and the 
S401A.  This was a preliminary run, and indicated that the S401D, phosphomimetic 
PP2A-Aα had a higher binding affinity followed by the WT and S401A mutant. High-
resolution and more extensive modeling studies as well as in vivo binding studies need to 
be pursued to establish a relationship between CRM1 and the PP2A-Aα (WT, S401A and 
S401D) forms. More importantly, we wish to understand how this binding is affected in 
response to DNA damage.  
 
 
We further looked at effect of LMB in the WT PP2A-Aα KO MEFs in the presence and 
absence of DNA damage. Our studies show that on treatment with Leptomycin B alone, 
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the PP2A-Aα seemed to accumulate in the nucleus. With IR alone, the PP2A-Aα was 
cytoplasmic, whereas when the cells were treated with Leptomycin B prior to IR 
treatment, we could still see the PP2A-Aα accumulating in the nucleus. This observation 
aligned with our hypothesis that post DNA damage, PP2A-Aα is exported to the 
cytoplasm via CRM1. 
 
Furthermore, to have a visual handle on the nuclear export of PP2A-Aα, we used a 
photoactivatable PP2A-Aα (PAmCherry- PP2A-Aα). We activated the PP2A-Aα in 
presence and absence of DNA damage (here pre-sensitization with Hoechst dye). In our 
preliminary experiment, we successfully activated the PAmCherry-PP2A-Aα. From our 
study, it looks like in cells pretreated with Hoechst, the exclusion of PAmCherry-PP2A-
Aα is faster and it seems to accumulate in the periphery of the nucleus. We are pursuing 
more studies to look at dose response and nuclear export kinetics using this tool, which 
will give us a better picture real time.  
 
The findings from this part of the studies are very exciting. The subcellular localization 
of the PP2A-Aα provides explanation for the extreme phenotypes we have seen in the 
S401 mutants. Therefore, based on studies from this chapter we speculate that post DNA 
damage, ATM kinase mediated phosphorylation on S401 of PP2A-Aα possible causing a 
conformational change in its structure, providing access to CRM1 binding. Subsequently 
CRM1 is exported from the nucleus (Fig. 4-6).  
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Figure 4-6: Model for CRM1 mediated PP2A-Aα nuclear export 
 
On DNA damage, ATM phosphorylates PP2A- Aα. This increases PP2A-Aα-CRM1 
binding and PP2A-Aα is exported to the cytoplasm. Inhibition on CRM1 with 
Leptomycin B will block this export. 
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CHAPTER 5: 
 
Generation of mouse model to conditionally knock 
out PP2A-Aα in the brain 
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Introduction    
 
 
 
Subcellular compartmentalization of PP2A is governed by the composition of the 
holoenzyme. Association with different subunits direct it to different locations and targets 
in the cells (Hiraga and Tamura, 2000; McCright et al., 1996; Sontag et al., 1995).  Our 
studies show that ATM, the major regulator of DDR, phosphorylates PP2A-Aα and 
subsequently causes its translocation to the cytoplasm. One of the characteristics of 
Ataxia-Telangiectasia (A-T) is neurodegeneration. ATM deficiency, leading to 
upregulation of PP2A activity, caused nuclear accumulation of HDAC4 (Li et al., 2012). 
This cytoplasmic loss of HDAC4 is partially responsible for neurodegeneration in 
patients with A-T (Li and Jiang, 2015).  
 
Strack et al. were the first to look at the subcellular localization of the different PP2A 
subunits in rat brain (Strack et al., 1998). They observed that certain B subunits are 
present in distinct neural populations and also they differ in their expression during brain 
development (Strack et al., 1998). There is a possibility that ATM-mediated regulation on 
PP2A-Aα can affect the formation of holoenzyme and alter its activity. PP2A-Aα is 
indispensible in adult mice (Ruediger et al., 2011). Ruediger et al. generated a mouse in 
which one PP2A-Aα was floxed and looked at the PP2A-Aα protein levels in different 
organs.  PP2A-Aα levels in most of the organs had 50% PP2A-Aα protein compared to 
the WT mouse except in the cerebellum, cortex and the brain stem where it was around 
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80% (Ruediger et al., 2011).  This study showed that in spite of presence of only one 
allele, the mouse brain acquired a way of maintaining higher levels of PP2A-Aα. 
 
We therefore set forth to investigate further the role PP2A-Aα in the brain. To study this 
we are generating a mouse model in which PP2A-Aα is specifically knocked out in the 
brain. It has been long known that the class IV intermediate filament nestin is a neuronal 
stem cell marker (Cattaneo and McKay, 1990; Johansson et al., 1999; Lendahl et al., 
1990). In this study, we are working on generating two lines of nestin-Cre mice. Our goal 
is to knock out PP2A-Aα in the central and peripheral nervous system as well as the 
neuronal precursors and glial cell precursors. We plan to express floxable alleles of 
PP2A-Aα (loxp flanking exon 5 and 6) (Ruediger et al., 2011) with Cre-recombinase 
under the control of Nestin promoter.  For deletion of DNA segment of a gene, a gene is 
targeted with two lox sites flanking the DNA segment to be deleted. The lox sites are 34 
bp long and, in presence of Cre recombinase, recombination takes place and the region 
between the loxP sites is excised (Sauer, 1987).  
  
Another line of nestin-Cre mice, which express Cre recombinase post tamoxifen 
administration, will help us to study the effect of PP2A-Aα loss in adult mice. These mice 
will express the transgene (CreERT2) triple mutant (G400V/M543A/L544A) of the 
estrogen receptor ligand-binding domain (Feil et al., 1997). Tamoxifen binds to the ERT2 
treatment causes translocation of CreERT2 to the nucleus where Cre will cause the 
recombination between two lox sites and flox out the exons 5 and 6 of PP2A- Aα 
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(Ruediger et al., 2011), thereby preventing the gene expression. Here, the CreERT2 will be 
fused to the nestin promoter.  
 
Apart from A-T, PP2A is also involved in Alzheimer’s disease (AD). Increased tau 
phosphorylation is a hallmark of AD. Dysregulation of PP2A has been implicated in 
increased tau phosphorylation (Sontag et al., 2004). Given the importance of PP2A-Aα in 
brain and various neuropathologies, it is important to study its role. Not much is known 
about the ATM/PP2A regulation in the neurons post DDR. Our model will allow us to 
look at the ATM mediated PP2A-Aα regulation in brain and its effect on neuronal 
signaling.  
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Material and methods 
 
Mouse information used to generate mice lines with brain specific KO of PP2A-Aα 
Fvb.129s-PPP2R1ATM1wltr/j mice were purchased from Jackson Laboratory as stock 
number 017441. These mutant mice possess loxp sites flanking exons 5-6 of the Aα gene 
(PPPP2R1A) of PP2A (Ruediger et al., 2011). We also purchased B6.Cg-Tg (Nestin-
Cre)1Kln/J from Jackson Laboratory as stock number 003771. The Nestin-Cre transgenic 
mice express Cre recombinase in central and peripheral nervous system, including normal 
and glial cell precursors (Tronche et al., 1999). The Nestin –CreERT2 mice were a 
generous gift from R. Hen (Dranovsky et al., 2011). All animal breeding and experiments 
have been approved by Virginia Commonwealth University, IACUC.  
 
Verification of nestin-GFP mice 
One-day-old pups were imaged with IVIS imaging system (PERKin Elmer). The GFP 
positive pups were then kept in separate cages.    
 
Genotyping 
Mice were ear punched about a week post weaning. DNA from the ear punches was 
isolated using a High pure PCR template preparation kit (Roche Diagnostics 
Corporation). The PP2A-Aα and Cre alleles were verified using PCR (described in 
Chapter 1.). 
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Results 
 
Generation of nestin-Cre – PP2A-Aα KO mice  
 
 
Brain specific knock out of PP2A-Aα will help us understand the role of this protein in a 
number of neurological processes. To generate mice with PP2A-Aα in the brain, we 
employed the Cre-lox system. The targeting strategy is outlined in Fig. 5-1. To generate 
these mice we bred PPP2R1ATM1wltr/tm1wltr (see Chapter 2.) with B6.Cg-Tg(Nes-
cre)1Kln/J (Fig. 5-2A). The F1 litter was a mix of different genotypes. We screened for 
mice that were positive for nestin-Cre nestin-GFP and PPP2R1ATM1wltr/ j. This was 
verified by genotyping (Fig. 5-2B). Currently, we are in the process of breeding the F1 
littermates. The F2 litters, which are fit for our experiments, will be the one which are 
homozygous for PP2A-Aα CKO alleles (PPP2R1ATM1wltr/tm1wltr) and have the nestin-Cre 
and nestin-GFP alleles. The F2 mice, which have the homozygous for PP2A-Aα CKO 
alleles but lack the nestin-Cre, will serve as control (Fig. 5-2B). Studies have shown that 
PP2A-Aα is indispensible for the whole mice. Also, in the presence of only one copy of 
PPP2R1A, the expression of Aα is more than 50% in the brain (Ruediger et al., 2011). 
Therefore, we are not very optimistic that our F2 litter will survive. However, if they do 
we will have a better insight on the effect of PP2A-Aα loss in the mouse brain at the time 
of development. By looking at markers of neuronal integrity we can understand if and 
how loss of PP2A-Aα affects neurodegeneration. If we don’t obtain a F2 litter, we can  
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Figure 5-1: Strategy for knocking out PP2A-Aα in mouse brain using nestin-Cre 
recombinase 
 
Representation of the WT, CKO and KO alleles of PP2A-Aα before and after Nestin-Cre-
mediated knock out. 
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Figure 5-2: Mouse breeding scheme for generating Nestin–Cre/PP2A-Aα mice and 
verification by genotyping 
 
(A) Strategy for nestin-Cre mediated knock out of PP2A-Aα in mouse brain. (B) 
Representative genotyping data. The PP2A-Aα primers generated a 263-bp product for 
WT allele and a 417-bp product for the CKO allele for the two heterozygous mice. The 
Cre primers verified that one mouse expressed a Cre-Recombinase and the other did not. 
study the heterozygous animals and monitor for any phenotypic changes in them over 
time. 
A 
B 
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Generation of Tamoxifen-inducible nestin-CreER – PP2A-Aα CKO mice  
 
 
Since there is a possibility that nestin-Cre /PP2A-Aα (CKO/CKO) mice may not survive, 
we decided to generate another mouse line in parallel.  We procured the tamoxifen-
inducible nestin-CreERT2 mouse line from Dr. R Hen. These mice have Cre recombinase 
fused to triple mutant (G400V/M543A/L544A) of the estrogen receptor ligand-binding 
domain (Feil et al., 1997). Post tamoxifen administration, tamoxifen will bind to the ERT2 
fused to Cre, and cause translocation of CreERT2 to the nucleus where it will mediate 
inactivation of the gene. The CreERT2 fusion is expressed under nestin promoter 
(Dranovsky et al., 2011). These nestin-CreERT2 mice were bred with F2 mice from the 
previously mentioned litter (nestin-CRE X 129S-PPP2R1ATM1wltr/tm1wltr), which were 
homozygous for PPP2R1A CKO alleles, were nestin-GFP but negative for nestin-Cre 
(Fig. 5-4A). The F1 litter was a mix of different genotypes. We screened for mice, which 
were positive for nestin- CreERT2, nestin-GFP and PPP2R1ATM1wltr/ j. This was verified 
by genotyping (Fig. 5-4B). At present, we are breeding the F1 littermates. The F2 
generation mice, suitable for our experiments, are the ones, that are homozygous PP2A-
Aα CKO alleles (PPP2R1ATM1wltr/tm1wltr), nestin-GFP positive and have the nestin-
CreERT2 allele. The F2 mice, which have the homozygous for PP2A-Aα CKO alleles, but 
lack the nestin-CreERT2 allele, will serve as controls. Once the animals are 8-10 weeks.   
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Figure 5-3: Schematic representation of tamoxifen inducible Nestin-CreERT2 system 
 
CreERT2  is expressed under nestin promoter. Post tamoxifen administration, tamoxifen 
will bind to the ERT2 fused to the Cre, and cause the translocation of CreERT2 to the 
nucleus where it will inactivate the PP2A-A via Cre-mediated recombination at loxP. 
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Figure 5-4: Mouse breeding scheme for generating tamoxifen inducibe Nestin –
Cre/PP2A-Aα mice 
 
 
(A) Strategy for tamoxifen inducible nestin- CreERT2 mediated knock out of PP2A-Aα in 
mouse brain. (B) Representative genotyping data. The PP2A-Aα primers generated a 
263-bp product for WT allele and a 417-bp product for the CKO allele for the two 
heterozygous mice. The Cre primers verified that both the mouse expressed Cre-
Recombinase.  
A 
B 
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old, tamoxifen will be administered to them once a day for 5 days. We will then take the 
brains out; isolate DNA for genotyping as well as look at PP2A-Aα protein levels to 
verify brain specific knock out  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
115 
 
 
Chapter summary  
 
 
 
We have reviewed in the previous chapter that PP2A holoenzyme is involved in 
regulation of complex signaling networks. The aim of this this study is to understand the 
role of PP2A-Aα in neuronal signaling in DDR.  
 
PP2A has been implicated in AD. In brains of patients suffering from AD, the levels of 
PP2A-A, C and Bα subunits were substantially reduced, subsequently reducing the 
phosphatase activity in the brain and causing severe phosphorylation of tau (Sontag et al., 
2004). Furthermore, increased T307 phosphorylation of the PP2A-C-subunit co-related 
with the rich phospho-tau neurons in the AD post moterm brains (Liu et al., 2008). There 
exits an overwhelming amount of evidence that associates dysregulated PP2A with the 
phospho-tau pathology in AD. Currently work is being done towards targeted therapy 
against PP2A to lower the phospho-tau pathology (reviewed in Sontag and Sontag, 2014).  
 
The role of PP2A in other neurological disorders is still emerging. In a large-scale study 
of undiagnosed developmental disorders in 1133 children and their parents, 4 de novo 
PPP2R5D (B56δ) and 3 de novo PPP2R1A (Aα) mutations were identified (The 
Deciphering Developmental Disorders Study, 2015). In a follow up study (Houge et al., 
2015), de novo mutations in the B56δ and Aα resulted in dysregulation of PP2A activity 
and was one of the causes for intellectual instability in the patients assessed.  Functional 
studies revealed that cases with B56δ were impaired in binding the A and C subunit 
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whereas in cases with Aα mutations, subunit A bound the B56δ but not the C-subunit 
affecting the total phosphatase activity (Houge et al., 2015).  
 
These studies indicate that mutations in the Aα or other regulatory subunits can affect the 
integrity of the enzyme, resulting in deleterious effects. Our mouse model system will 
help us study the role of PP2A-Aα in the brain. We have so far successfully generated 
Nestin-Cre as well as the nestin-CreERT2 F1 lines.  We are currently breeding the F1 
mice to generate the F2 mice with the required PP2A-Aα (CKO/CKO) genotype. Studies 
in these mice will enable us to study the brain specific role of PP2A-Aα in diverse 
processes. 
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CHAPTER 6: 
 
Conclusions 
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Discussion  
 
 
 
Understanding how the cell deals with genomic instability is of utmost importance. DSBs 
are the most lethal form of DNA damage, which can have deleterious consequences on 
the cell. The DDR elicited by the cell in response to genotoxic stress determines if the 
damage needs to be repaired or if the cell should proceed via the cell death pathway. 
Uncovering specific players and the mechanism by which they are regulated can open 
new avenues in therapeutics. The DDR is a coordinated response between phosphatases 
and kinases, which aids in determining the cell’s fate. Phosphorylation and 
dephosphorylation acts as an ON/OFF switch for signaling proteins and directs them 
towards or away from their target.  
 
 
In the previous chapters we have reviewed the extensive role of PP2A in diverse cellular 
functions. It has a crucial part in the specific cell cycle checkpoints activated by DDR as 
well as activation and inhibition of key players involved in DNA repair. ATM, the master 
regulator of DDR, is maintained in its native inactivated state by PP2A-mediated S1981 
dephosphorylation. The PP2A-A and ATM interaction is disrupted post IR mediated 
DNA damage. Studies have shown that ATM can also exert control on PP2A by 
phosphorylating it on a S401 residue of the Aα subunit and inhibiting the holoenzyme’s 
activity (Li et al., 2012). Furthermore, studies from our lab also indicate that ATM can 
regulate pro-survival molecules like AKT in response via a PP2A-like phosphatase 
(Golding et al., 2009). Also, viral antigens, like Polyomavirus middle t (PyMT) and SV40 
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small t-antigen, facilitate cell transformation by inhibiting PP2A activity. The antigens 
bind to PP2A by replacing the B subunit (Mumby, 1995). Golding et al observed that 
ATM inhibition in cells over-expressing PyMT had elevated p-AKT (S473) levels 
(Golding et al, unpublished) suggesting a role of PP2A downstream of ATM. In this 
study we have addressed how ATM-mediated phosphorylation on S401 of PP2A-Aα 
modulated pro-survival signaling and DDR and also deciphered the mechanism 
underlying the phenotype we observed. 
 
We verified the ATM-mediated phosphorylation on PP2A-Aα by in vitro kinase assay. 
Also, our in vitro studies show that the PP2A-Aα binds to the FAT kinase domain of 
ATM. Using molecular modeling, Dr. Mostafa Ahmed (Kellogg lab), simulated 
phosphorylation on the S401 of PP2A-Aα. These studies revealed that p-S401-PP2A-Aα 
potentially undergoes a conformational change in silico. Immunoprecipitation in HEK293 
cells expressing the WT, S401A and S401D PP2A-Aα form, reveal that the S401D 
PP2A-Aα was unable to bind ATM, AKT as well as the catalytic subunit. This suggests 
that phosphorylation at the S401 causes a structural change in the PP2A-Aα subunit, 
which could result in the dissociation of the complex. Our observation of impaired 
binding of the phosphomimetic S401D to the C-subunit could perhaps result in the loss of 
its phosphatase activity. 
 
Here, we have developed a genetic system to study how a posttranslational modification 
on a single residue can affect the DDR signaling. Our initial experiments were aimed at 
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generating PP2A-Aα knockout MEFs, which were complemented with the PP2A-WT, 
S401A or S401D forms. The cells were characterized for the knock out of the 
endogenous PP2A-Aα and expression of the WT and the S401A and S401D forms. We 
further examined these cells for any characteristic differences.   
 
MEFs expressing the phosphomimetic S401D had increased growth rate and showed 
increased p-AKT (S473) levels post insulin treatment. When we assessed the basal p-
AKT (S473) levels in the three PP2A-Aα KO MEFs, we saw no significant difference. 
However the p-ERK1/2 levels were elevated in the S401D-expressing MEFs. This 
suggests that ATM mediated phosphorylation on S401 of PP2A-Aα possibly upregulates 
pro-survival signaling via the MAP kinase pathway instead of PI3KK pathway. However, 
we need to assess other players like the upstream regulators in the MAP kinase pathway. 
PP2A can regulate MAP kinase pathway both positively and negatively; also, studies 
have shown that elevated p-ERK can negatively feed into PI3K pathway (Lehr et al., 
2004; Sontag et al., 1993b; Westermarck et al., 1998).  
 
PP2A regulates ATM and other DDR proteins involved in processes like cell cycle check 
points as well as key players that mediate DNA repair. Our studies show that DDR 
elicited by MEFs expressing S401A and S401D is highly misregulated. Both the mutant 
cells harbored aberrant chromosomes, the frequency of which increased post DNA 
damage. Perhaps, this accumulation of genomic instability caused increased 
radiosensitization in these cells, as seen in our clonogenic survival assay. The S401D 
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cells displayed delayed γ-H2AX dephosphorylation kinetics implying unrepaired damage. 
The S401D-expressing cells were impaired in both HRR and c-NHEJ whereas the S401A 
cells were impaired in HRR but not in c-NHEJ where it could possibly function by 
upregulating the activity of DNA-PK.  
 
The most exciting finding of our study was that the S401D mutant was localized in the 
cytoplasm whereas the S401A was more nuclear and the WT PP2A-Aα was both nuclear 
and cytoplasmic. We supposed that the phosphorylation on the S401 subunit causes its 
translocation to the cytoplasm. To validate this, we looked at nuclear export mechanisms. 
We found a nuclear export signal (NES) in the PP2A-Aα protein that is targeted by the 
CRM1 protein. Our immunoprecipitation studies show that CRM1 bound to PP2A-Aα in 
vivo. Also, on inhibiting CRM1 in the WT MEFs, the PP2A-Aα accumulated in the 
nucleus. DNA damage by irradiation in the WT cells caused the PP2A-Aα to translocate 
to the cytoplasm, which was prevented to some extent by CRM1 inhibition. The NES is 
located close to the S401 site on the HEAT repeats of PP2A-A; therefore, the 
phosphorylation at S401 could affect PP2A-Aα-CRM1 binding.   
 
Many of our findings can be explained by the altered localization of these mutants in 
their phosphorylated and unphosphorylated form. The delayed γ-H2AX 
dephosphorylation kinetics in the S401D-expressing MEFs could be due to cytoplasmic 
sequestration of S401D PP2A-Aα. Since this cytoplasmic form of PP2A-Aα does not 
have access to its nuclear substrates, this can further affect the quality of repair and lead 
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into accumulation of genomic abnormalities. PP2A has vital functions in cell cycle 
checkpoints, especially mitotic entry and exit.  Cytoplasmic sequestration (S401D) or 
nuclear retention (S401A) of PP2A-Aα can result in early or delayed mitotic entry or exit. 
PP2A also regulates the proteins like Sgo1 and Plk1, which are crucial for integrity of the 
kinetochores and in spindle assembly checkpoint. Dysregulation can result in deleterious 
effects like mitotic catastrophe.  
 
Taken together our findings suggest that, in response DSBs induced by IR, ATM is 
activated and then phosphorylates PP2A-Aα on S401. This phosphorylation may result in 
a conformational change in the scaffolding subunit increasing its affinity to CRM1 and 
thereby causing its export to the cytoplasm. Meanwhile, ATM-mediated DDR is 
upregulated in the nucleus as seen by the increased γ-H2AX levels which then recruits 
DNA repair factor to initiate repair. Checkpoint activation follows as the cell assesses the 
damage in the nucleus, while in the cytoplasm. PP2A-Aα reassembles with C and B 
subunits and dephosphorylates pro-survival signaling proteins leading to growth arrest. 
During the damage recovery phase, PP2A-Aα is dephosphorylated in the cytoplasm and 
shuttles back to the nucleus where it can dephosphorylate γ-H2AX to ensure efficient 
DNA repair. A model is outlined in Fig. 6, depicting how we believe this occurs.  Thus, 
S401 seems like a key residue which when phosphorylated, governs timely nuclear 
export as well as import of PP2A-Aα, which is essential for accomplishing a DDR. 
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Figure 6: Model depicting how ATM mediated phosphorylation on PP2A-Aα 
regulates DDR and prosurvival signaling   
 
ATM phosphorylates myriad of proteins in response to IR including H2AX at S139 and 
PP2A-Aα at S401 thereby initiating the DDR and triggering cell cycle checkpoints and 
growth arrest, and DSB repair inhibition. Soon after DDR is intiated, PP2A-Aα 
translocates to the cytoplasm which reduces PP2A activity in the nucleus allowing the 
DDR with its highly phosphorylated protein landscape to run its course. At the same time, 
AKT and other growth-promoting factors and signaling pathways are inhibited by the 
increased PP2A activity in the cytoplasm while the damage is assessed and repaired. 
Soon after the DDR is beginning to subside, PP2A-Aα shuttles back to the nucleus where 
it increases PP2A-Aα activity and begin to engage DSB repair while γ-H2AX and other 
DDR targets are dephosphorylated. When repair is completed and cells resume cycling, 
growth recovers. 
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Future directions 
 
 
 
We have unraveled a very specific mechanism by which DDR in part is orchestrated. 
However, there are many questions that still remain unanswered. As of now there are 
many ongoing experiments for this project that are not yet complete. The results from 
these studies will back up many of our studies as well as clarify some of the mechanisms 
that appear open-ended at this point.  
 
We observed that both the S401A and S401D mutants were inefficient in HRR, whereas 
the S401D-expressing cell were also deficient in NHEJ. In spite of two major DSB repair 
pathways being impaired, the S401D cells continue to survive, concurrently accumulating 
aberrant chromosomes. We therefore think that a backup DSB repair pathway such as alt-
EJ, which is highly error-prone, is mediating repair in these cells.  We are currently in the 
process of verifying this by using a reporter alt-EJ cassette (Gunn and Stark, 2012).  
 
Our studies show that the mitosis is severely dysregulated in the S401A and the S401D 
mutant cells. Studies have shown that inhibition of PP2A can affect HRR by aberrant 
CDK1 activation and as well as accumulation of active Plk-1. We therefore plan to look 
at several checkpoint proteins in the MEFs that express the WT, S401A and S401D forms 
of PP2A-Aα. The B56 subunits are crucial for regulating mitotic entry and exit. Co-
immunoprecipitation for the B56 subunit and others with the WT, S401A and S401D 
forms of PP2A-Aα will help us understand the regulatory aspect. 
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Our data show that PP2A-A and CRM1 exist together in an immune-complex. We are 
presently in the process of looking at CRM1 and PP2A-Aα (WT/S401A/S401D) 
interaction using Proximity Ligation assay (PLA). PLA will give us a better insight on 
where the interaction is occurring and how is this interaction affected on DNA damage or 
CRM1 inhibition. In order to look closely at CRM1 mediated PP2A-Aα shuttling, we 
have generated site-specific mutations in the putative NES sequence (L373A) by itself as 
well as in combination with the S401A and S401D mutation. These mutants are 
expressed in the photoactivatable PAmCherry background. Photoactivation of these 
various mutants in presence and absence of DNA damage will allow us to look at nuclear 
export in real time.   
 
Finally, our mouse model, in which we aim to knock out PP2A-Aα in the brain, will pave 
a way to many avenues. In the Nestin-Cre /PP2A- Aα (CKO/CKO) model, if the 
CKO/CKO mouse survives, we will be able to assess phenotypic changes when the Aα 
alleles are lost during development. Once we have a generated a PP2A-Aα (CKO-CKO) 
expressing the Nestin-CreERT2, tamoxifen treatment in adult mice will facilitate knock 
out of PP2A-Aα. We will be primarily looking for any drastic phenotypic changes in the 
animals. If the animals don’t survive, their brains will be analyzed for morphological 
changes or neurodegeneration markers. For both the models, we also plan to isolate 
neural progenitors from PP2A-Aα (CKO-CKO) /Nestin-CreERT2 pups. This will aid us in 
looking at neural signaling affected with PP2A-Aα in the cells.  
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All these studies which are currently being undertaken along with the studies performed 
for this project will give us an important insight on functioning of the ATM/PP2A-Aα 
signaling. Both, ATM and PP2A are potential therapeutic targets for treating a number of 
cancers and neurological disorders owing to their complex functions. Our study will help 
to broaden our understanding of the spatiometric regulation of ATM and PP2A in DDR.  
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Appendix A 
 
 
 Primer name Primer Sequence (5' to 3') 
   
1 PPP2R1A (11609-11631) #1 GAGGACAAGTCTTGGCGTGTTCG 
2 PPP2R1A (11871-11848) #2 CATGGAGTTGAAACTTGGCTTCAG 
3 PPP2R1A (10709-10732) #3 TCACTGGACACTGTACTTCAGCAG 
4 Cre Recombinase 5' (1083F) GCGGCATGGTGCAAGTTGAATAA 
5 Cre Recombinase 3' (1085R) GTGAAACAGCATTGCTGTCACTT 
6 Actin 5'  TCACCCACACTGTGCCCATCTACGA 
7 Actin 3' CAGCGGAACCGCTCATTGCCAATGG 
8 Repair assay 5' CGGAGCAAGCTTGATTTAGGTG 
9 Repair assay 3' CGCATGAACTCTTTGATGACCTC 
10 Ampicillin 5' TGTGCAAAAAAGCGGTTAGCT 
11 Ampicillin 3' GCGGCCAACTTACTTCTGACA 
 
Table 1: List of Primers used  
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